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Summary
Clathrin coated vesicles were the first type of coated vesicle to be
characterised. The coat consists of two components, clathrin and adaptor (or
AP) complexes, the AP-1 complex is associated with the clathrin coated
vesicles that bud from the TGN and the AP-2 complex is associated with the
clathrin coated vesicles that bud from the plasma membrane.
A new type of adaptor-like complex was discovered in our laboratory and was
published in 1996. The complex has been shown to consist of two known
proteins, b 3B and m 3B, and two unknown proteins of 160kD and 22kD. Unlike
the conventional adaptor complexes this complex is not associated with
clathrin.
The aim of this thesis was to complete the characterisation of the adaptor-like
complex and to establish its function. My studies have shown that, the
adaptor-like complex consist of a a /g  like subunit, d , a b  subunit ( b 3A/B), a m
subunit ( m 3A/B) and a s  subunit (s 3A/B). We named the adaptor-like complex
AP-3, by analogy with the AP-1 and AP-2 complexes. The AP-3 complex is
localised to perinuclear and more peripheral membranes in non-neuronal
cells, with little overlap with endocytic markers. The b  subunit of the AP-3
complex is the major target for phosphorylation. Analysis of mice with
mutations in the b 3A subunit, and in the d  subunit of the AP-3 complex, have
revealed that the b  subunit is required for the stability of the m  subunit and that
the d  subunit is essential for the stability of the whole complex. Further
analysis of the mutant mice indicated that the mice lack significant levels of
functional AP-3 complex. Studies on fibroblasts generated from these mice
revealed that the AP-3 complex plays a role in the trafficking of LAMPI to
lysosomes.
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1Chapter 1
Introduction
A characteristic feature of any eukaryotic cell is the organisation of its
cytoplasm into a complex set of membrane bound organelles. This
compartmentalisation allows the cell to perform many different, and
sometimes competing, biochemical reactions. These compartments have a
defined lipid and protein composition that must be maintained if the organelle
is to remain functional. The organisation of the cytoplasm raises several
questions including, how are proteins and lipids transported between these
organelles and how is the composition of these defined structures
maintained? There have been many studies investigating these questions,
however three key studies outline the basic principals of protein and lipid
transport in the endocytic and secretory pathways: vesicle budding, vesicle
targeting and vesicle fusion.
Biochemical and electron microscopy studies by G. Palade on exocrine
pancreas tissue indicated that proteins could move in a vectorial fashion
between distinct organelles of the secretory pathway via vesicular
intermediates (Palade, 1975). Morphological studies by Roth and Porter on
the endocytic pathway of mosquito oocytes showed that the formation of
endocytic carrier vesicles was driven by the formation of a bristle coat on the
membrane, and raised the possibility that the coat could both enable the
vesicle to form and select the vesicle cargo (Roth and Porter, 1964).
Biochemical in vitro reconstitution studies by Rothman have indicated that
there are mechanisms for regulating the fusion of transport vesicles to the
correct acceptor membrane, by the pairing of specific vesicle and membrane
associated transmembrane proteins (SNARE hypothesis) (Sollner et al.,
1993). A combination of these mechanisms (cargo selection and targeted
fusion) would provide selectivity in vesicular transport and thus help to
maintain the integrity of these distinct organelles.
21.1 Overview of the Secretory and Endocytic Pathways
Secretory pathway
Proteins destined for the secretory pathway are co-translationally inserted into
the endoplasmic reticulm (ER) where they are proteolytically processed,
folded and acquire covalent modifications (O and N-linked glycosylation,
palmitoylation, and disulphide formation) (Ng and Walter, 1994). Proteins that
have not folded properly are either retained in the ER until they have correctly
folded or are exported into the cytoplasm and degraded (Hebert et al., 1996;
Pilon et al., 1997). Proteins that are not ER resident are exported from the ER
to the Golgi complex via the intermediate compartment. Escaped ER resident
proteins are retrieved from this compartment and directed back to the ER
(Barlowe, 1998; Lowe and Kreis, 1998).  Other proteins are transported to the
Golgi stack, where they undergo sequential processing as they transit through
the Golgi cisternae (carbohydrate modification and tyrosine sulphation).
The Golgi complex structurally consists of several flattened stacked
membranes termed the cis, medial and trans cisternae, each cisternum is
defined by the presence of a specific set of glycosyltransferases.  The cis-
Golgi contains N-acetylglucosamine (GlcNAc)-1-phosphodiester a -N-
acetylglucosaminidase that is required for the addition of mannose-6-
phosphate residues to the oligosaccharide chains of lysosomal hydrolases.
The medial cisternum contains GlcNAc-transferase I and the trans cisternae
contains the majority of sialyltransferase, a terminal sugar processing enzyme
(Fullekrug and Nilsson, 1998). However each enzyme is found in more than
one cisternum, indicating that there is a gradient of processing enzymes
throughout the Golgi stack (Nilsson et al., 1993). Proteins are then
transported to the trans-Golgi network (TGN) where they are sorted and
transported via vesicular intermediates to various destinations within the cell
including the plasma membrane, endosomes and/or lysosomes .
3Endocytic pathway
Cells internalise material from the extracellular environment via many
methods (receptor mediated endocytosis, macropinocytosis, phagocytosis
and caveolae). Receptor mediated endocytosis is the best characterised
endocytic process and involves the efficient internalisation of molecules
bound to cell surface receptors.
Molecules such as LDL  (low density lipoprotein), EGF (epidermal growth
factor) and transferrin are bound by cell surface receptors and internalised via
clathrin-coated vesicles.  These vesicles pinch off from the cell surface,
uncoat and fuse with early endosomes. The receptors and ligands have
several possible fates. The receptor and ligand can be recycled back to the
cell surface (e.g., the transferrin receptor). The ligand can dissociate from its
receptor in the acidic environment of the endosome, with the receptor being
recycled back to the cell surface (e.g., the LDL receptor). The receptor and
ligand can be targeted further into the endocytic pathway for degradation in
lysosomes (e.g., the EGF receptor) (Schmid, 1997).
The morphology of the endocytic pathway is very complex consisting of
interconnected tubules and vesicles, however three main classes of
organelles have been defined biochemically and morphologically. Early
endosomes are found in the cell periphery and are the first structures to be
labelled with internalised tracers. Early endosomes can be further subdivided
into "sorting" and "recycling" endosomes (sorting endosomes contain both
transferrin and LDL, however, recycling endosomes only contain transferrin).
It is thought that Late endosome (pre-lysosomes) are found closer to the
nucleus and label strongly for M6P receptor but not the transferrin receptor
and often contain internal membranes. Lysosomes are the most acidic
endocytic structures, they do not contain M6P receptor, are very rich in acid
hydrolases and often have electron dense cores (Gruenberg and Maxfield,
1995) (Griffiths and Gruenberg, 1991).
4The secretory and endocytic pathways can not be considered separate
entities as newly synthesised endosomal and lysosomal proteins are targeted
into the endocytic pathway and certain proteins also cycle between the
endocytic and secretory pathways (furin, TGN38 and M6P receptor) (Le
Borgne and Hoflack, 1998).
A common feature shared between the endocytic and exocytic pathways is
the use of coated carrier vesicles to shuttle membranes and proteins between
distinct compartments. Several distinct types of coated carrier vesicle have
been identified and characterised, including COPI, COPII and clathrin-coated.
Each coat consists of a distinct set of proteins; however, many of the
mechanisms regulating the processes of vesicle formation and cargo
selection are conserved between these coat complexes. I have mainly
focused my introduction on the mechanisms involved in the biogenesis of
clathrin-coated vesicles although many of the points discussed also apply to
the generation of other types of coated vesicles.
1.2 Clathrin-coated vesicles
Clathrin-coated vesicles were first observed by Roth and Porter in the early
1960s. Roth and Porter were studying yolk protein uptake in mosquito
oocytes. They observed that during yolk uptake the surface of the oocytes
became invaginated and numerous vesicles appeared just under the cell
surface. Both the invaginations and vesicles were covered with a bristle like
coat. They speculated that the formation of the invaginations might be driven
by the formation of the coat on the membrane, and the coat might also be
playing a role in the selection of the content of the vesicle (Roth and Porter,
1964). The true nature of the bristle coat only became apparent when coated
vesicles were isolated from guinea pig brains and negatively stained,
revealing that the coat consisted of a polyhedral lattice (Kanaseki and Kadota,
1969). In 1975 the bristle coated vesicles were purified to near homogeneity
and identification of the protein composition of the coat became possible
(Pearse, 1975).
5Clathrin heavy and light chains
The major protein in purified coated vesicles was a protein of 180kD which
was named clathrin (Pearse, 1975). Two other proteins of 33kD and 36kD
also consistently co-purified with clathrin and were named (LCa and LCb)
(Pearse, 1978). Crosslinking studies indicated that soluble clathrin consists of
a trimer of 3 heavy chains and 3 light chains (Kirchhausen and Harrison,
1981). Negative staining indicated that the trimer forms a three-legged
structure joined at the centre (or vertex) called a triskelion (Ungewickell and
Branton, 1981). Morphologically three regions in each leg are distinguishable;
there is a bend approximately midway which subdivides the leg into a 17nm
long proximal segment (close to the vertex) and a 25nm long distal segment.
A globular domain is joined to the distal segment via a flexible linker
(Kirchhausen et al., 1986) (Fig. 1.1a). Interestingly, purified clathrin triskelions
under suitable conditions can reassemble in vitro into polyhedral cages
resembling the lattice structures observed on coated vesicles, suggesting
clathrin is the major structural component of the coat (Crowther and Pearse,
1981).
Clathrin heavy chain is ubiquitously expressed in all eukaryotes and sequence
comparisons between species show that it is highly conserved (Kirchhausen
et al., 1987; Pley and Parham, 1993). Saccharomyces cerevisiae clathrin
heavy chain is ~50% identical to rat heavy chain. A second clathrin heavy
chain has been identified, CLH2, which is ~85% identical to CLH1. CHL2 is
also ubiquitously expressed but is most highly expressed in skeletal muscle
(Kedra et al., 1996). The high degree of homology shared between the two
isoforms would suggest that they are performing similar functions.
Higher eukaryotes ubiquitously express two types of clathrin light chain, LCa
and LCb, that are ~60% identical to each other. In neurons there are two
additional forms LCa and one additional form of LCb created by differential
splicing (Ponnambalam et al., 1994). S. cerevisiae only express one form of
clathrin light chain that is 18% identical to LCb (Brodsky et al., 1991).
6Function of the clathrin heavy and light chains
The ability of the clathrin heavy chains to self-assemble in vitro into a regular
polygonal lattice indicates that the heavy chains act as a structural scaffold for
the budding vesicle. The role of the light chains is still unclear. It is known that
clathrin heavy chains can self-assemble in the absence of light chains
(Winkler and Stanley, 1983), and the absence of the light chains does not
effect the lattice's stability. However under these conditions the assembly of
lattices is no longer calcium dependent in vitro (Ungewickell and Ungewickell,
1991). Clathrin light chains contain a calcium binding domain so they have
been proposed to play a role in regulating clathrin assembly (Mooibroek et al.,
1987). Interestingly yeast lacking clathrin light chain have the same
phenotype as yeast lacking clathrin heavy chain, indicating that clathrin light
chains are required in vivo for vesicle formation (Silveira et al., 1990).
Clathrin structure
As mentioned earlier the basic building block of the polyhedral lattice is the
triskelion. The structure of the lattice has been determined by cryo-electron
microscopy on clathrin cages embedded in vitreous ice. The simplest cage
consists of 12 pentagons and 6 hexagons (36 triskelions) (Crowther and
Pearse, 1981; Smith et al., 1998) (Fig. 1.1b).  A study by Heuser (1980), gave
an indication of how clathrin-coated vesicles might be formed in vivo. The
study revealed that the plasma membrane is coated with clathrin-coated
structures that range from being flat sheets consisting of only hexagons to
curved structures that contained both hexagons and pentagons. He proposed
that the curvature of the lattice can be changed by altering the ratio of
hexagons and pentagons (Heuser, 1980). It is still unclear what mechanisms
exist to facilitate this process.
Two papers have recently been published that increase our understanding of
clathrin heavy chain structure and function. The N-terminal globular domain
(terminal domain) and a region of the proximal domain of the clathrin heavy
chain have recently been crystallised and their structures solved (ter Haar et
al., 1998; Ybe et al., 1999).  The N-terminal globular domain forms a seven
7bladed beta propeller similar to that found in the beta subunits of
heterotrimeric G proteins. Several prominent grooves are formed by this
structure that potentially could be sights of protein binding. From the cro-
electron microscopy studies it is known that the propeller region is orientated
so it is facing into the inside of the vesicle (Crowther and Pearse, 1981; Smith
et al., 1998). This orientation would allow the propeller domain to interact with
proteins that are involved in cargo selection. Interestingly, the binding of beta
arrestin (Goodman et al., 1997), and b  adaptin (personal communication, Dr
T. Kirchhausen) to clathrin has been mapped to one of these groves (beta
arrestin is thought to play a role in the internalisation of heterotrimeric G
proteins (Kirchhausen et al., 1997)).
A section of linker that connects the propeller to the distal leg was also
resolved in the ter Haar et al. study. The linker region is made up of
alternating short alpha helices connected by loops that form a zigzag
structure. The structure formed is thought to provide a flexible linker between
the propeller and the distal leg. The structure of the proximal domain also has
a zigzag type motif formed by alternating alpha helices. However the structure
of the proximal domain is more organised than the distal linker domain, thus
suggesting the proximal domain is not as flexible. The proximal domain plays
a role in clathrin light chain binding and clathrin heavy chain-heavy chain
interactions, so the crystal structure should help define residues that are
required for these processes.
Clathrin adaptor interactions
The second major component of clathrin-coated vesicles are adaptor
complexes. Adaptor complexes were initially isolated from coated vesicles by
Pearse and Robinson (1984). Cryo-electron microscopy studies revealed that
the adaptor complexes form a layer between the vesicle membrane and the
clathrin lattice (Vigers et al., 1986a; Vigers et al., 1986b). Clathrin cage
assembly in vitro only occurs under non-physiological conditions such as low
pH~6.5 and low ionic strength buffers. The clathrin cages that are formed
under these non-physiological conditions are of a non-uniform size. However
8the addition of adaptor complexes allows the clathrin cages to assemble
under more physiological conditions and the cages that are formed are of a
more uniform size (Zaremba and Keen, 1983).
1.3 Adaptor Complexes (AP-1 and AP-2)
Adaptor composition and structure
Two types of adaptor  (AP-1 and AP-2) were purified from clathrin-coated
vesicles and separated by their different elution profiles on hydroxyapatite
(Pearse and Robinson, 1984) (Fig. 1.2). Crosslinking studies indicated that
adaptors are heterotetrameric complexes consisting of two ~100kD
polypeptides named adaptins, and two smaller proteins of ~50kD and ~20kD
(Ahle et al., 1988; Keen, 1987b; Virshup and Bennett, 1988). The AP-1
complex consists of g -adaptin (~97kD), b 1-adaptin (~105kD), m 1 (47kD) and
s 1 (~19kD). The AP-2 complex consists of a -adaptin (~105kD), b 2-adaptin
(~105kD), m 2 (~50kD) and s 2 (~17kD) (reviewed by Robinson
1992)(Robinson, 1992).
Rotary shadowing studies on purified AP-2 complexes indicated that the
adaptor complexes form a brick-like core "head" attached to two smaller
appendages "ears" via flexible linkers (Heuser and Keen, 1988). Treatment of
purified AP-2 with elastase results in removal of the "ears", as only the
adaptor core was visualised by rotary shadowing. Analysis of the digested
AP-2 complexes by SDS-PAGE revealed that the two adaptins had been
cleaved. Sequencing of the digested adaptins revealed that the ears
correspond to the C-terminal portions of b  and a  adaptins (Kirchhausen et al.,
1989).
Adaptor genes
The AP-1 and AP-2 subunits have been cloned and are highly conserved
between mammalian species. Sequence comparison between a /g -adaptin and
b -adaptin reveal that there is homology between these proteins indicating they
are derived from a common ancestor. There is also homology between the
9small subunits and the medium subunits. Adaptors subunits also share limited
homology with coatomer subunits, b  COP shares homology to b  adaptin, g
COP with g  adaptin, d  COP with m , z  COP with a (Lowe and Kreis, 1998).
b 1 and b 2 are ubiquitously expressed and are highly related to each other
(~84% identical).  There is also a alternatively spliced form of b 2 expressed
only in neurons that has a 14 amino acid insert in its hinge region
(Ponnambalam et al., 1990).
In mammalian cells there are two ubiquitously expressed isoforms of a -
adaptin, a A and a C, which are 80% identical and encoded by two genes
(Robinson, 1989). It is not known if a A and a C are functionally equivalent but
both isoforms have been shown to be present in the in the same coated pits.
a A is also alternatively spliced in brain tissue with an extra 22 amino acids in
its hinge domain (Ball et al., 1995).
There are also two ubiquitously expressed isoforms of g -adaptin, g  and g 2,
which are ~60% identical to each other (Robinson, 1990) (Lewin et al., 1998;
Takatsu et al., 1998). g 2 has recently been described and it can assemble into
an AP-1 complex's. However, it is not clear if g  and g 2 have distinct
localisations within the cell. However g 2 can bind g -adaptin's binding partner g -
synergin, indicating the two isoforms may have similar functions (W. Lui,
personal communication).
The medium subunits m 1 and m 2 are ubiquitously expressed and are 39%
identical to each other. Recently a new m  isoform has been described, m 1B,
which is ~79% identical to m 1 and is only expressed in epithelial tissue. The
restricted expression of m 1B might indicate that m 1B is involved in polarised
trafficking (Ohno et al., 1999).
The small subunits s 1 and s 2 are ubiquitously expressed and are ~42%
identical to each other. Recently a new s  isoform has been described, s 1B,
which is ubiquitously expressed and is ~87% identical to s 1. Yeast two hybrid
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studies have indicated that s 1B can interact with g -adaptin and may therefor
co-assemble into classical AP-1 complexes (Page et al., 1999; Takatsu et al.,
1998).
Homologues of the various adaptor subunits have been identified and cloned
in many species. The other main organism where research into adaptor
complexes has been performed is Saccharomyces cerevisiae. Genetic and
biochemical studies have indicated that the yeast genes APL4, APL2, APM1
and APS1 encode proteins that are equivalent to g , b 1, m 1 and s 1 of the AP-1
complex and that this complex might associate with clathrin (Phan et al.,
1994; Rad et al., 1995; Stepp et al., 1995). It has also been proposed that the
products of the genes APL3, APL1, APM4 and APS2 may encode a complex
equivalent of the AP-2 complex in yeast but there is no functional data to
support this (Cowles et al., 1997a). Recently a third adaptor complex has
been identified and characterised in yeast, AP-3. Unlike the yeast AP-1
complex it does not interact with clathrin (discussed later) (Cowles et al.,
1997a; Panek et al., 1997; Stepp et al., 1997).
Subunit interactions
Crosslinking studies on AP-2 adaptor complexes, using a reversible
crosslinker, indicated that there were close associations between the various
subunits of the complex (Virshup and Bennett, 1988). A fully crosslinked
complex ran with a molecular weight of 260kD on SDS-PAGE consistent with
a composition of all four subunits. Partially crosslinking revealed intermediates
species of 200kD, 150kD and ~110kD. The 200kD species is probably
composed of the two adaptins, the 150kD species is m 2 plus one of the
adaptins and the 110kD species is probably one of the adaptins associated
with s 2. The group were unable to determine which of the adaptin subunits
were associated with the smaller subunits. The above findings were
supported by a study performed by Page and Robinson 1995. Using the yeast
two hybrid system they were able to detect interactions between the two large
adaptins subunits of the AP-1 and AP-2 complexes ( b  and a / g ,) interactions
between the b  and m  subunits and interactions between the a /g  and s  subunits
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(Page and Robinson, 1995). Interestingly the coatomer subunit that share
homology to the adaptor subunits also interact in the yeast two hybrid system
in a similar manner as b  and m  and a / g  and s  (i.e. g  and z  COP interact, and b
and d  COP interact) (Faulstich et al., 1996).
Adaptor localisation
Antibodies raised against a  and g -adaptins demonstrate that the AP-1 and AP-
2 complexes are localised to distinct compartments. The anti- a  antibody
labels the plasma membrane and the anti-g  antibody mainly labels the
perinuclear region of the cell (Ahle et al., 1988; Robinson, 1987). By immuno-
electron microscopy AP-1 positive coated pits are localised predominantly to
the trans-Golgi network and partially colocalise with the M6P receptor
(Klumperman et al., 1993). AP-1 staining is also present on endosomal
structures (Futter et al., 1998). In addition, in specialised secretory cells AP-1
staining is present on immature secretory granules (Dittie et al., 1996). These
findings indicate that the AP-1 complex may have multiple functions.
1.4 Function of adaptor complexes and clathrin
Biochemical studies
Structural studies indicated that the adaptor complexes are positioned
between the clathrin lattice and the vesicle membrane (Vigers et al., 1986b),
so it was proposed that adaptors play a role in the binding of clathrin to the
membrane. Several biochemical studies support this hypothesis. Membranes
can be treated under conditions that strip clathrin from the membrane but
leave the adaptors still bound (Unanue et al., 1981; Wiedenmann et al.,
1985). If these stripped membranes are then treated with elastase (to cleave
the adaptors) the clathrin is unable to rebind to the membranes. Further
support for this hypothesis comes from experiments where the AP-2 complex
is mistargeted on to an endosomal compartment by the addition of GTP g S.
Clathrin was found to follow the mistargeted AP-2 on to the endosomes
(Seaman et al., 1993).
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The localisation and concentration of molecules such as the transferrin
receptor and M6P receptor into clathrin-coated vesicles, led to the hypothesis
that adaptor complexes might be playing a role in the selection of these
molecules. Biochemical binding studies have indicated that adaptor
complexes are able to bind to the cytosolic transmembrane tails of molecules
such as the LDL receptor, M6P receptor and LAMPI (lysosomal associated
membrane protein I) (Pearse, 1988) (Glickman et al., 1989) (Honing et al.,
1996). These bindings studies indicate that adaptor complexes are potentially
able to interact and possibly concentrate molecules into clathrin-coated
vesicles.
Genetic studies
Genetic studies have given several insights into adaptor and clathrin function
in vivo.  The clathrin gene has been disrupted in two unicellular organisms,
yeast and Dictyostelium (Lemmon and Jones, 1987; O'Halloran and
Anderson, 1992; Payne et al., 1987; Payne and Schekman, 1985).
Surprisingly both organisms are viable although growth is impaired. In clathrin
knock out yeast, Kex2p (processing protease) and dipeptidyl aminopeptidase
A (DPAP A) are mislocalised from the TGN to the cell surface, although the
sorting of carboxy peptidase Y (CPY) to the vacuole is unimpaired.
Interestingly, when a temperature sensitive mutant of clathrin heavy chain is
initially shifted to the restricted temperature a defect in the sorting of CPY to
the vacuole is observed, however after a few hours the CPY missorting defect
is no longer detected.
Surprisingly, disrupting all four subunits of the AP-1 complex in yeast causes
no obvious sorting defect. A study by Huang et al. (1999) has recently been
published that indicates that disruption of yeast AP-1 and AP-2 complexes
and the yeast AP180 homologues (clathrin assembly proteins) all in the same
strain does not lead to a clathrin deletion-like phenotype, and that the clathrin-
coated vesicles in these cells are indistinguishable from clathrin-coated
vesicles isolated from a wild type strain (Huang et al., 1999). Their findings
indicate that in yeast clathrin is able to function in the absence of adaptor
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complexes and assembly proteins. However, it is not known whether there are
other proteins in yeast that may function like adaptor complexes (e.g. b
arrestin).
Clathrin heavy chain and several of the adaptor subunits have also been
disrupted in multicellular organisms. The clathrin heavy chain has been
disrupted in Drosophilia melanogaster and has been found to be essential
(Bazinet et al., 1993). Disruption of the a -adaptin gene in Drosophilia also
leads to embryonic death. m 1A and g -adaptin have both been knocked out in
mice and both are essential and lead to early embryonic death (Zizioli et al.,
1999). Cells have been generated from the m 1A knock out embryos and the
trafficking of several proteins investigated. M6P receptor traffics more via the
cell surface in these cells compared to wild type cells, however that trafficking
of LAMPI appears to be unaffected (Dr Peter Schu, personal communication).
These findings indicate that AP-1 complex is required for the efficient
trafficking of the M6P receptor in vivo. These findings indicate that adaptor
complex's are not essential for unicellular function, however in mullticellular
organisms they are essential.
1.5 Adaptor subunit function
Clathrin binding
The localisation of adaptor complexes between the vesicle membrane and the
clathrin lattice, and the ability of adaptors to promote clathrin assembly in vitro
indicates that adaptors can directly interact with clathrin. In vitro binding
studies indicated that adaptor complexes are able to bind to the terminal
globular domains of clathrin heavy chains and are also able to bind the hub
regions of clathrin triskelions (Hanspal et al., 1984; Murphy and Keen, 1992).
As the crystal structure of the terminal globular domain is now known potential
adaptor binding sites can be investigated by mutagenesis studies.
The high degree of homology shared between b 1 and b 2 subunits made them
likely candidates for directly interacting with clathrin. Initial in vitro binding
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studies indicated that recombinant b 2 could stimulate clathrin cage assembly
and also could compete with AP-2 for the binding of these cages (Ahle and
Ungewickell, 1989; Gallusser and Kirchhausen, 1993). Using recombinant b 2
fusion proteins the clathrin binding domain of b 2 was mapped to the hinge
region (Shih et al., 1995). However there have been no in vivo studies to
confirm these in vitro observations.
Cargo selection
Three sorting signals have been clearly identified that play a role either in the
endocytocis of molecules from the cell surface or their efficient targeting within
the cell: YXXø, FXNPXY and di-leucine motifs (X stands for any amino acid
and ø stands for a bulky hydrophobic amino acid) reviewed by Le Borgne and
Hoflack (1998) (Le Borgne and Hoflack, 1998). A study by Ohno et al. (1995)
screened a yeast two hybrid library with the cytoplasmic tail of TGN38
(SDYQRL) to search for interacting proteins. Several clones were isolated
from the library screen and two of them encoded the m 2 subunit. Alanine
mutagenesis of this sequence indicated that the binding of m 2 to the TGN38
tail domain was dependent on the tyrosine and leucine amino acids. These
amino acids had also been shown in vivo to be important for the endocytocis
of TGN38. The TGN38 tail's sequence is also able to bind to m 1 in the yeast
two hybrid system. In contrast, the YXXø of the transferrin receptor only
binds to m 2 and not m 1 in the yeast two hybrid system. The different affinities
of the tails for either m 1 or m 2 could explain why certain molecules are
trafficked by different adaptor complexes.
The crystal structure of a recombinant m 2 bound to the tail of TGN38 was
resolved in 1998 by Owen and Evans (1998). The tyrosine residue and the
bulky hydrophobic residue that are critical for the correct sorting of TGN38
binds into two hydrophobic pockets formed by two parallel beta strands in the
medium subunit. The tyrosine binding pocket forms many hydrogen bonds
with the hydroxyl group of the tyrosine residue in the peptide. These hydrogen
bonds are essential for the correct binding of tyrosine containing peptides as
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either changing the tyrosine to phenylalanine in the peptide or mutating an
aspartic acid residue (Asp176 is conserved in all of the medium subunits
identified) in the binding pocket inhibit the binding of the peptide (Nesterov et
al., 1999; Owen et al., 1999).
Di-leucine motifs are also thought to bind to adaptor complexes but it is
controversial which adaptor subunit of the complex the peptides bind to ( b  or
m )(Bremnes et al., 1998; Rapoport et al., 1998; Rodionov and Bakke, 1998).
Crosslinking studies have indicated that di-leucine containing peptides may
interact with the b  subunits of the AP-1 and AP-2 complexes. This result is
supported by studies performed by Marks et al. (1996). When they
overexpressed proteins containing YXXø motifs in vivo they found that the
cells ability to endocytose molecules that contain YXXø signals was reduced
but the trafficking of proteins that contain di-leucine signals was unaffected, so
suggesting that di-leucine signals do not interact with the medium subunit
(Marks et al., 1996).
Targeting
In order for adaptor complexes to function in cargo selection they first must be
targeted to the correct membrane. The a  and g -adaptin subunits appear to be
good candidates for this role in the adaptor complex as they share only limited
homology. Transfection studies using a /g  chimeras have indicated that there is
some weak targeting information in the a /g  ear domains although the majority
of the targeting information resides in the N-terminal head domain (Page,
1996; Robinson, 1993).  Studies by Benmerah et al. (1999) have shown that
the a  ear domain on its own is able to correctly target to the plasma
membrane (Benmerah et al., 1999), confirming the observation that there is
targeting information in the ear domains. The a  ear dependent targeting may
in part be due to large number of interactions the a  ear undertakes at the
plasma membrane (discussed later). The N-terminal portion that is important
in targeting the adaptor complex to the correct membrane also determines
whether m 1 and s 1 or m 2 and s 2 assembled into the complex, thus it is likely
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that the m  and s  subunits play a role in their complexes targeting to the correct
membrane.
Binding of accessory proteins
The a  and g  ear domains have been shown to play a role in the binding of a
series of molecules that may modulate or regulate the budding of clathrin-
coated vesicles. There are at least 4 molecules that can directly bind to a -
adaptins ear domain amphiphysin: Eps15, epsin and AP180 (CALM) (David et
al., 1996) (Benmerah et al., 1996; Chen et al., 1998; Hao et al., 1999).
Mapping of the Eps15 and epsin a  ear binding domains have revealed that
these domains contain a tripeptide repeat DPF or DPW. Interestingly
amphiphysin and AP180 also contain these repeats (Marsh and McMahon,
1999).
The crystal structure for the a  adaptin ear domain has been published by two
groups: Owen et al. (1999) and Traub et al.  (1999). The a  ear domain is split
into two subdomains, one consisting entirely of b  sheets (N-terminal) and one
that consists of b  sheets and a  helices (C-terminal). Using the crystal structure
to predict potential binding pockets both groups performed mutagenesis
studies on the a  ear, and investigated the ability of the mutated recombinant
ears to interact with binding partners. Both groups identified residues in the
same C-terminal area that when mutated affected the binding of Eps15,
AP180, epsin and amphiphysin. The area they identified was very small
suggesting that only one binding partner could bind to this domain at one time
(Owen et al., 1999) (Traub et al., 1999). In vitro binding studies have indicated
that the DPF peptide can bind to the a  ear and the peptide is also able to
inhibit the binding of amphiphysin (Owen et al., 1999).
Amphiphysin, Eps15 and epsin can also interact with several other molecules;
amphiphysin interacts with dynamin (a GTP binding protein), synaptojanin
(inositol-5-phosphatase; cleaves PIP2) and endophilin (lysophosphatidic acid
acyl transferase; generates phosphatidic acid) (endophilin can also interact
with synaptojanin) (de Heuvel et al., 1997; Micheva et al., 1997; Schmidt et
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al., 1999); epsin can also bind Eps15 and Ese1/2 (Ese1/2, DAP 160 and
intersectin all share homology) (Chen et al., 1998) (Roos and Kelly, 1998;
Sengar et al., 1999). Interestingly several of these molecules also contain
repeated sequences.
The EH (Eps15 homology) domain is approximately 100 amino acids in length
and there are three EH domains in Eps15 (Wong et al., 1995), while
intersectin (Ese1/2, DAP160) contains two EH domains (Roos and Kelly,
1998; Sengar et al., 1999).  The EH domain of Eps15 has been shown to bind
the tripeptide NPF (Salcini et al., 1997). Interestingly epsin, AP180 and
synaptojanin (non-neuronal isoforms) contain NPF repeats.
Amphiphysin, intersectin and endophilin all contain Src homology 3 domains
(SH3). This domain has been shown to bind to proline-rich domains in
proteins (Shupliakov et al., 1997). Interestingly, synaptojanin and dynamin
have these proline-rich domains. These studies indicate that a very complex
array of protein-protein interactions can be formed by the binding of very
simple protein motifs. The exact function of this protein network is still not
know, however overexpressing domains of several of these proteins inhibit
endocytosis (Marsh and McMahon, 1999), indicating that these proteins might
regulate the process of clathrin-coated vesicle formation.
A g -adaptin ear binding protein g -synergin has recently been described by
Page et al. (1999). This molecule is the first g  ear binding protein to be
identified. The protein can be alternatively spliced and ranges in size from
~110-190kD depending on the tissue examined. Like Eps15, g -synergin
contains an EH domain indicating that g -synergin will be able to bind
molecules containing NPF motifs. However, unlike Eps15 g -synergin is not
associated with AP-2, but with both cytosolic and membrane bound AP-1.
Interestingly g -synergin is mislocalised to the plasma membrane in cells
expressing a construct that has had the g  ear fused onto the a -trunk. This
result indicates that g -synergin plays no role in the targeting of the AP-1
complex to membranes. The g  ear binding domain of g -synergin has been
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mapped and contains no DPF sequences, however there are 5 repeats of this
sequence DDFXD/EF. The crystal structure of the g  ear has been resolved,
and the structure is very similar to the N-terminal domain of the a  ear.
However, the g  ear does not contain the domain on the a  ear that has been
shown to be required for the binding of amphiphysin, Eps15 and epsin (Dr
David Owen, personal communication). This observation indicates that g -
synergin will not bind to the g  ear in the same way as Eps15 binds to the a
ear.  The function of g -synergin is still to be resolved.
1.6 Adaptor recruitment
Membrane binding
The precise localisation of adaptor complexes to specific membranes in the
cell suggests that there must be signals on the membranes that the AP
complexes can recognise and potentially bind to. Several studies have
suggested that cargo molecules such as the transferrin receptor or the M6P
receptor provide the specificity of for adaptor localisation (Le Borgne et al.,
1993; Miller et al., 1991), however this seems unlikely as these molecules are
also present in compartments that do not recruit adaptors. Several studies
have indicated that there might be adaptor receptors.  A study by Virshup and
Bennett (1988) identified a high affinity AP-2 binding site on salt stripped
membranes (Virshup and Bennett, 1988). It has also been shown that the
binding of adaptors to salt stripped membranes is a saturable process,
suggesting that there is only a limited number of receptors for adaptor binding
(Moore et al., 1987). Several attempts have been made to identify molecules
that might act as cargo receptors. Mallet and Brodsky (1996) used an AP-1
affinity column to isolate proteins of 83 and 52kD from detergent extracted
cells (Mallet and Brodsky, 1996). Seaman et al. (1996) performed crosslinking
studies on recruited cells, and found that several proteins (p60, p75 and p80)
were specifically crosslinked to AP-1 (Seaman et al., 1996). Unfortunately in
both cases the identity of these molecules still remains unknown.
Synaptotagmin has been proposed to be a high affinity docking site for AP-2
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(Haucke and De Camilli, 1999; Zhang et al., 1994), however there is no data
that indicates that synaptotagmin is required for AP-2 recruitment in vivo.
Regulation
Fractionation studies have shown that adaptor complexes are distributed
between the cytosol and membranes of the cell (Simpson et al., 1996). For
adaptor complexes to function they must be recruited from the cytosol on to
the membrane, and regulation of this process is essential if vesicular
trafficking is to be controlled. Information on the regulation of adaptor
recruitment has mainly come from in vitro studies making use of
permeabilised cells and membrane fractions. These studies have indicated
that regulation of adaptor recruitment is not simple and many factors influence
the process.
AP-1 recruitment in vitro is stimulated by GTP g S and inhibited by the fungal
metabolite brefeldin A. Treatment of cells with brefeldin A in vivo causes the
AP-1 complex to redistribute into the cytosol (Robinson and Kreis, 1992).
There is evidence that both GTPg S and brefeldin A are acting via the ARF
family of small GTP binding proteins. GTP g S causes the ARF to become
constitutively active while brefeldin A inhibits the nucleotide exchange of
ARFs. The mechanism of brefeldin A action has recently been identified.
Brefeldin A stabilises ARF-GDP bound to it exchange factor so creating the
equivalent of a dominant negative mutant (Chardin and McCormick, 1999).
Direct evidence for the role of ARFs in AP-1 recruitment came from several
studies; firstly the recruitment of AP-1 was reduced when cytosol was
depleted of ARF1 by fractionation, secondly the only cytosolic components
required for AP-1 recruitment in vitro were recombinant myristoylated ARF1
and purified AP-1 (Seaman et al., 1996; Stamnes and Rothman, 1993; Traub
et al., 1993). The mechanism of ARF action is not clear and might be different
for each ARF, however ARF1 has been shown to activate phospholipase D
(PLD) (Cockcroft et al., 1994).  Interestingly the addition of exogenous PLD or
inhibitors of PLD have been shown to effect COPI recruitment (Ktistakis et al.,
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1995; Ktistakis et al., 1996), however exogenous PLD or PLD inhibitors do not
effect AP-1 recruitment (West et al., 1997). These results suggest that the
mechanism of ARF1 action might be different for each type of coat complex.
The mechanisms involved in AP-2 recruitment are also not clearly defined.
The localisation of AP-2 complex is not sensitive to brefeldin A in vivo and in
vitro, however GTP g S causes the AP-2 complex to be mistargeted on to an
endosomal compartment. The addition of exogenous PLD or constitutively
active ARF1 also causes AP-2 to be targeted to endosomes. The addition of
neomycin (PLD inhibitor, also binds PIP2) to these experiments not only
inhibits the misslocalisation of AP-2 to endosomes but also its recruitment on
to the plasma membrane (West et al., 1997). These findings indicate that the
generation of phosphatidic acid or PIP2 may be involved in the recruitment of
the AP-2 complex onto the plasma membrane.
1.7 Novel adaptor complexes
There are many membrane traffic pathways in the cell that are not mediated
by the three well characterised types of coats (clathrin, COPI and COPII), and
this has led to the suggestion that there must be additional coat proteins to
carry out these pathways (Robinson, 1991). This hypothesis is supported as
two new adaptor complexes have been identified, AP-3 and AP-4.
AP-3
The first indication that there might be a new adaptor-like complex came from
a study performed by Pevsner et al.  (1994), who cloned cDNAs that had
homology to m 1 (AP47) and m 2 (AP50). Pevsner et al. (1994) screened an
electric ray cDNA expression library with an antiserum raised against electric
ray synaptic vesicles. One of the clones isolated, ray p47, was used to screen
a rat brain cDNA library, resulting in the isolation of rat p47A (m 3A) and p47B
( m 3B). Northern blotting indicated that m 3A was ubiquitously expressed and
that m 3B's expression was restricted to neuronal tissue. m 3A and m 3B are
~80% identical to each other and ~28-30% identical to m 1 and m 2 (Pevsner et
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al., 1994). The low degree of homology of m 3A and m 3B with the conventional
medium subunits suggests that they are not just isoforms of m 1 and m 2 and
might be components of new adaptor-like complex.
The next adaptor-like subunit to be cloned was cloned by Newman et al.
(1995), who isolated a cDNA that had homology to b 1 and b 2 and was named
b -NAP (for neuronal adaptin-like protein). Newman et al. (1995) isolated b -
NAP ( b 3B) by screening a human brain cDNA expression library with an
autoimmune serum. Like m 3B, b 3B is only expressed in neuronal tissue. b 3B
is ~28% identical to b 1 and b 2. An antiserum was raised against recombinant
b 3B, and the protein was found to be present both in the cytosol and
associated with membranes. This result is consistent with b 3B potentially
being a coat component (Newman et al., 1995). If b 3B is a component of a
novel AP-like coat complex, the complex should consist of two large subunits
(one of which is b 3B) a medium subunit and a small subunit, by analogy to the
known adaptor complexes.
A study by Simpson et al. (1996) raised antiseria against b 3B and m 3 and
used them in a range biochemical studies to investigate if m 3 and b 3B are
components of a novel adaptor-like complex. Gel filtration studies indicated
that m 3 was a component of a larger complex as m 3 fractionated with an
apparent size of ~400kD, consistent with it being a component of an adaptor-
like complex. Immunoprecipitation studies using either anti- b 3B or m 3
antibodies indicated that the two proteins are part of the same complex and
co-immunoprecipitate with a unknown proteins of ~160kD and ~25kD.
Western blotting studies using an anti-m 3 antibody indicated that even though
m 3 is related to m 1 and m 2 it is not enriched in clathrin-coated vesicles.
In vitro recruitment studies indicated that the m 3/ b 3B complexes ability to bind
to membranes is regulated in a GTP-dependent manner like AP-1 and AP-2.
Immunofluorescence microscopy studies using the anti- b 3B antibody
indicated that the m 3/ b 3B complex is localised to perinuclear and more
peripheral regions within the cell. Immunoelectron microscopy studies
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indicated that the m 3/ b 3B complex is localised to a tubular vesicular network
that also labelled with antibodies against AP-1 and clathrin. The m 3/ b 3B
complex and AP-1/clathrin staining are often in very close proximity but do not
colocalise, indicating that the m 3/ b 3B complex is not associated with clathrin.
At the time the work described in this thesis was begun the study by Simpson
et al. (1996) had just been completed. However, several issues were left
unresolved. Do the 160kD and 25kD proteins share homology with a /g  and s
adaptor subunits? What is the function of the AP-3 complex? Interestingly
several ESTs had been identified by Dr M. S. Robinson that encode proteins
that share homology to a /g  and s 1/s 2 adaptor subunits, and these proteins
were candidates for the 160kD and 25kD proteins. An indication of the novel
complex's function came from yeast two hybrid studies performed by Ohno et
al.  (1995). Ohno et al.  (1995) showed that m 1 and m 2 in vitro were able to
bind to peptides that contained tyrosine-based motifs (Ohno et al., 1995).
These signals had previously been shown to be important in the trafficking of
many proteins (TGN 38, LAMPI, LAMPII). As the novel complex was known to
contain a medium subunit ( m 3) it seemed likely that this complex would also
play a role in the sorting of proteins containing tyrosine-based motifs.
AP-4
Studies by Hirst et al. (1999) and Dell'Angelica et al. (1999) have recently
described the cloning and characterisation of a fourth adaptor-like complex.
Like conventional adaptor complexes, the complex consists of a a /g  like
subunit e , a beta subunit b 4, a medium subunit m 4, and a small subunit s 4
(Dell'Angelica et al., 1999a; Hirst et al., 1999). Northern blotting studies
indicated that all four subunits of the AP-4 complex are expressed
ubiquitously. The AP-4 complex, like the AP-1 and AP-3 complexes, is
brefeldin A sensitive indicating that the association of the AP-4 complex with
membranes is regulated in an ARF dependent manner. Immunofluorescence
studies by Hirst et al. (1999) indicate the AP-4 complex is expressed at very
low levels and is localised to the perinuclear region within the cell. Immuno-
electron microscopy studies by Hirst et al. (1999) have indicated that the AP-4
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complex is localised to the trans-Golgi network of the cell. Yeast two hybrid
studies by Hirst et al. (1999), have shown that the m 4 subunit, like m 1, m 2 and
m 3, is able to interact with proteins that contain tyrosine-based motifs. The
ubiquitous expression and the low abundance of the AP-4 complex would
suggest that the complex participates in a specialised trafficking pathway that
is required in all cells.
1.8 This thesis
The aim of this thesis was to complete the characterisation of the AP-3
adaptor-like complex and to establish its function.
ab
Figure 1.1
Schematic diagram of a clathrin triskelion (a) and a schematic diagram of triskelion 
packing to form a clathrin lattice (b). Each triskelion is composed of three clathrin
heavy chains and three light chains. The globular N-terminal domain points towards
 the membrane. The vertex of each triskelion forms the vertex of the polyhedral coat.
Diagrams obtained from C.L. Ball.
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Schematic digram of the two adaptor complexes.
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Chapter 2
Materials and Methods
2.1 Materials
Plasmids
pBluescript (SK/KS) was obtained from Stratagene. The pGEX (3X and 4T)
family of vectors were obtained from Pharmacia Biotech. The mammalian
expression vectors pCEP, pREP and b - Galactocidase pcDNA3 were
originally obtained from Invitrogen. The mammalian expression vector pMEP
modified from pMEP (Stratagene) was a generous gift from Dr G. Banting
(Roquemore and Banting, 1998). GFP (S65T) pcDNA3 was a generous gift
from Dr J. Haseloff (Siemering et al., 1996).
Bacterial strains
The bacterial strains used during this study included TG2 (plasmid
amplification), MC1061 (GST fusion protein production), DH5a  (plasmid
amplification and GST fusion protein production), SCS110 (plasmid
amplification) and C600-Hfl ( l gt10 library host strain).
Bacterial culture media
Bacterial cultures were grown in 2xTY (1.6% tryptone, 1% yeast extract, 0.5%
NaCl, pH 7.4), supplemented with 50 m g/ml ampicillin when required.
The M.R.C Laboratory of Molecular Biology media kitchens provided bacterial
growth media and plates.
Oligonucleotides
Oligonucleotides were made by Genosys Biotechnologies. The sequences of
the oligonucleotides used in this study are shown below, restriction sites are
underlined. The oligonucleotides used for the sequencing of b 3A and b 3B are
not listed.
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Table 2.1 Sequence of oligonucleotides
sequence use of oligonucleotides
CGCGGATCCCAGTAGACAAGGTTCACAATA
(BamHI)
PCR of C terminus of s 3 A
for  GST fusion protein
CCGGAATTCTTTGTATGGATCACAAGTGCA
(EcoRI)
                       "
CGCGGATCCCCGACCCATCAGTTCGA
(BamHI)
PCR of b 3A hinge for GST
fusion protein
AGGCCCGGGATCTTTGGTAAGAGGAGT
(SmaI)
                       "
GGTTAATTAAGCGGCCGC
(PacI) (NotI)
5’ polylinker for b 3A
GGCCGCTTAATTAACCGC
(PacI)
                       "
GGTGATGGCGGTGGCGC PCR to construct missing
region of b 3B
TTTGATGATCTCTCCATGTTGTGCTGGCTGCA
TCTGT
                       "
AACATGGAGAGATCATCAAACACTTGGCAAAG
CTTAC                        "
GGTGGGACAGTGAGCCC                        "
ACGCGTCGACATGAGTAAAGGAGAAGAACTT
(SalI)
PCR of GFP
ACGCGGGCCCTTATTTGTATAGTTCATCCATG
CC
(ApaI)
                       "
Antibodies
The antibodies used and generated in this study are shown on the next two
pages.
Table 2.2 Antibodies
Antibody Antigen Source Application Reference
AP-6
a -adaptin F. Brodsky IF (1:50) (Chin et al.,
1989)
Anti- s 1 s 1 M.S. Robinson WB (1:100) (Page and
Robinson,
1995)
Anti- s 3A s 3A this study I P /  W B
(1:100)
(Simpson et
al., 1997)
Anti- s 3B s 3B F. Simpson I P /  W B
(1:100)
(Simpson et
al., 1996)
Anti- m 1 m 1 M.S. Robinson WB (1:30) (Page and
Robinson,
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1995)
Anti- m 3A/B m 3A/B F. Simpson IP* (1:500)
WB (1:1000)
(Simpson et
al., 1996)
Anti- b 3A b 3A this study IP/WB
(1:100)
(Simpson et
al., 1997)
Anti- b 3B b 3B F. Simpson IP (1:100) /
WB (1:400)
(Simpson et
al., 1996)
Anti- b 3B b 3B Upstate
Biotechnology
IF (1:100) (Newman et
al., 1995)
Anti- g g- adaptin M. Seaman IF (1:400)
IP (1:100)
WB (1:1000)
(Seaman,
1994)
mab100/3 g -adaptin E. Ungewickell IF (1:50) (Ahle et al.,
1988)
Anti- d
(N terminus)
d F. Simpson IF (1:300)
IP (1:100)
WB (1:400)
(Simpson et
al., 1997)
Anti- d  (hinge) d M. Robinson IP/WB
(1:100)
Anti- d  (hinge +
ear)
d M. Robinson IP/WB
(1:100)
Anti-clathrin clathrin heavy
chain
M. Robinson IF/IP/WB
(1:100)
(Simpson et
al., 1996)
X22 clathrin heavy
chain
F. Brodsky IF (1:50) (Brodsky,
1985)
Anti-GST GST this study WB (1/1000) (Page et al.,
1999)
Anti-
transferrin
receptor
Transferrin
receptor
(CD77)
Serotec IF/EA (1:100)
Anti-LAMP I
(CD107a)
cell
membranes
DSHB IF/EA (1:100) (Chen et al.,
1985)
Anti-LAMP II
(CD107b)
cell
membranes
DSHB IF/EA (1:50) (Granger et
al., 1990)
Anti-alpha-2-
macroglobulin
receptor
cell
membranes
DSHB IF/EA (1:100) (Hughes and
August, 1981)
Pgp-1
(CD44)
cell
membranes
DSHB IF/EA (1:100 (Hughes and
August, 1981)
Anti- b -
galactocidase
b -
galactocidase
DSHB IF (1/20)
Anti-mouse
TR
mouse IgG Amersham IF (1:100)
Anti-rabbit
FITC
rabbit IgG Amersham IF (1:100)
Anti-rat TR rat IgG Molecular
Probes
IF (1:100)
Anti-rat rat IgG Sigma EA (1:1000)
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Anti-TR TR Molecular
Probes
EA (1:1000)
IP=Immunoprecipitation, IF=Immunofluorescence, WB=Western blotting,
EA=Endocytocis assay, DSHB=Developmental studies hybridoma bank,
TR=Texas red, FITC=Fluorescein iso thiocyanate
2.2 Molecular biology methods
General molecular biology procedures were performed according to standard
protocols unless otherwise stated (Sambrook et al., 1989). Reagents were
obtained from Boehringer Mannheim, Clontech, Invitrogen and New England
Biolabs.
Polymerase chain reaction (PCR)
The standard reaction conditions used are listed below:
2 m l of dNTP mix (10mM each dNTP)
10 m l of Vent DNA polymerase buffer (supplied with enzyme)
1 m l of template DNA (~ 5ng/m l)
2 m l of each primer (~ 10pmol/ m l)
0.5 m l of Vent DNA polymerase
84.5 m l of water (reactions final volume 100 m l)
The PCR reaction was then overlaid with mineral oil and the following PCR
program used:
94°C for 2 min (denaturation)
50°C for 1 min (annealing)
72°C for 2 min (extension)
This sequence was repeated 27x except the denaturation step (94°C) was
reduced to 1min. The last cycle the extension time was increased to 10
minutes.
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Restriction digests
Restriction digest was performed as instructed by the manufacturer using the
buffers supplied with the enzymes.
Agarose gels
After restriction digest the digested DNA was run on a TBE (90mM Tris-
borate, 2mM EDTA) agarose gel, with an agarose percentage ranging from
0.8% to 2% depending on the size of the DNA fragments to be resolved. The
QIAEX II Kit (Qiagen) was used to extract DNA from excised gel bands if they
were required for further processing.
Ligations
Cut insert and vector were ligated (ratio 10:1) by incubating overnight at 16°C
(sticky ligation) or 25°C (blunt ligation) with T4 DNA ligase in the buffers
supplied with the enzymes.
Blunt-end cloning of PCR products
The PCR product to be cloned was phosphorylated by incubating with T4
polynucleotide kinase at 37°C for 30 minutes (buffer supplied with enzyme).
The phosphorylated PCR product was then gel purified. Cut vector was
dephosphorylated by adjusting the restriction digest to optimal conditions by
the addition of phosphatase buffer (supplied with the enzyme). Alkaline
phosphatase was added and the reaction mixture was incubated at 37°C for
30 minutes. The dephosporylated vector was then gel purified. The
phosphorylated PCR product and dephosphorylated vector were then ligated
using T4 DNA ligase overnight at 25°C.
Preparation and transformation of calcium chloride competent bacterial cells.
Competent cells were prepared by inoculating 100ml of 2xTY with 1ml from a
overnight culture, the cells were grown at 37°C until a OD600 of between 0.7-
0.8 was reached. The cells were chilled on ice, pelleted and then
resusepended in 50ml of 0.1M CaCl2. After a 30 minute incubation on ice the
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cells were repelleted and resuspended in 5ml of 0.1M CaCl2 The competent
cells were allowed to mature at 4°C overnight before being used or snap
frozen in liquid nitrogen and stored at -80°C (10% glycerol was added to the
cells before freezing).
The DNA to be transformed was mixed with 100m l of competent cells and
incubated on ice for 5 minutes, the transformation mixture was then spread on
2xTY amp plates which had been prewarmed to 37°C (Pope and Kent, 1996).
Plasmid purification
Plasmid purification was carried out using the QIAprep Spin Miniprep Kit or
the QIAfilter Plasmid Midi Kit (Qiagen) following the manufacturers
instructions. Both kits are based on a modified alkali lysis procedure. The kits
utilise a silica matrix column which only binds DNA and allows contaminating
RNA and proteins to be washed through. The purified DNA is then eluted from
the silica matrix by changes in salt conditions.
DNA sequencing
DNA sequencing was initially carried out using Thermo SequenaseTM or
SequenaseTM V2 sequencing kits (Amersham) following the manufacturers
instructions. When an automated sequencing facility became available, a
Perkin Elmer fluorescent automated sequencer was used (University of
Cambridge Biochemistry Department sequencing facility). DNA for automated
sequencing was prepared using QIAprep Spin Miniprep Kits. The DNA for
sequencing was diluted to 100ng/ m l in water; primers for automated
sequencing were used at to 10pmol/ m l.
Labelling DNA probes
Radioactive probes were generated using the Rediprime (Amersham) random
primer labelling kit. 25ng of denatured DNA was labelled with 32P-CTP in
accordance with the manufacturers instructions. The unincorporated 32P-CTP
was removed by passing the reaction products down a Nick column
(Sephadex® G-50 DNA grade column). The labelled probe was denatured by
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boiling and then snap cooled on ice before it was added to the hybridisation
solution.
Library screening
A human heart l gt10 library (Clontech) was screened according to the
instructions supplied by the manufacturer. The library was titred and plated
out on a lawn of C600Hfl bacteria at approximately 70,000 plaque forming
units per 150mm plate (10 plates were used). The plates were incubated at
37°C until the plaques had reached a suitable size (~8 hours). The plates
were chilled to 4°C before duplicate filter lifts were performed, using Hbond™-
N+ (Amersham) nylon membranes. The membranes were alkali fixed in
accordance with the manufacturers instructions.
The alkali fixed membranes were prehybridised in ExpressHyb™ (Clontech)
hybridisation solution for 30 minutes at 65°C, as indicated by the
manufacturers instructions. The prehybridisation solution was removed and
replaced with prewarmed (65°C) hybridisation solution containing 25-50ng of
denatured probe, and incubated at 65°C for 1 hour. The membranes were
washed for 40 minutes in 2xSSC containing 0.05% SDS at room temperature,
and 0.1xSSC containing 0.1% SDS for a further 40 minutes at 50°C. The
wash solutions were changed several times during the incubations. The wet
membranes were wrapped in plastic wrap and exposed to Kodak X-OMAT
film for the appropriate length of time to obtain a signal.
Positive plaques were identified by aligning the library plates with the X-ray
film, and were picked by using the large end of a Pasteur pipette. Secondary
and tertiary screens were performed until plaque purified clones were
obtained. The phage were amplified in liquid culture at 37°C until lysis of the
bacterial host strain had occurred. The phage were manually isolated and
their DNA purified using the Wizard Lambda Preps kit, as indicated by the
manufacturers instructions.
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Southern Blotting
Samples to be analysed were run on an agarose gel and transferred to
Hbond™-N+ nylon membranes by capillary transfer (Sambrook et al., 1989).
This method entailed incubating the agarose gel in denaturation solution
(1.5M NaCl, 0.5M NaOH) for 30 minutes at room temperature with gentle
agitation. The gel was rinsed in distilled water and transferred to neutralisation
solution (1.5M NaCl, 0.5M Tris-HCl pH7.2, 0.001M EDTA) for 30 minutes at
room temperature (the neutralisation solution was changed after 15 minutes).
The gel was incubated in 10xSSC (1.5M NaCl, 0.15M Na3 citrate) for 30
minutes at room temperature before the DNA was transferred on to nylon
membranes by capillary transfer over night. The membranes were alkali fixed
and the same hybridisation conditions used as previously described for library
screening.
Bioinformatics (DNA and protein sequence analysis)
The DNA and protein sequence manipulation program Gene Jockey
(BISOFT) was used to create DNA contigs for ( b 3A and b 3B), protein
sequence alignments for ( b 3A, b 3B, s 3A/B, m 3A/B and d ), hydropathy plots for
( b 3A, b 3B and d ) and predicted molecular weights for ( b 3A, b 3B, s 3A/B, m 3A/B
and d ) subunits of the AP-3 complex. The SIP (Staden, 1990) and MegAlign
(DNA STAR PACKAGE) software were used to compare and calculate the
identities of the subunits of the AP-1, AP-2 and AP-3 complex subunits. The
National Centre for Biotechnology Information (NCBI) databases were
searched for novel adaptor-like proteins using the NCBI BLAST program
(Karlin and Altschul, 1990).
2.3 Cloning strategies
Construction of full length b 3A
b 3A was isolated from a human heart cDNA library and excised from the
phage using EcoRI. This generated two fragments that were cloned into
pBluescript (SK). The two clones were sequenced and a cloning strategy was
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designed to create a full-length clone. The two clones were joined together
utilising a unique EcoRI site.
To aid the moving of b 3A into several expression vectors a polylinker was
added to the 5' end of the gene. The polylinker was created by annealing
complimentary oligonucleotides together containing PacI and NotI restriction
sites. The annealed complimentary oligonucleotides were cloned into the
SacII site of the b 3A cDNA in pBluescript.
Construction of full-length b 3B
As the cDNA clone encoding the full-length b 3B was unavailable the EST
database was searched for human clones that encoded b 3B. Several clones
were found which could potentially encode b 3B, GenBank accession numbers
175331(C1), 231345 (C3), 320375 (C2) and 165789 (C4). These clones were
obtained, restriction mapped, sequenced and aligned to b 3B (Fig 2.1a). None
of the clones encoded the full length b 3B, so a strategy was designed which
would involve cutting and pasting several of these clones together using
unique restriction sites (BamHI, NotI and HindIII) to create a nearly full-length
clone. The missing piece was generated by overlapping PCR and inserted
into the clone using unique sites (KasI and ApaI) (Fig 2.1b). To check that no
cloning artefacts had occurred the complete cDNA was sequenced in one
direction (the PCR fragment was sequenced in both directions).
Construction of full-length d
d  was isolated from  human heart cDNA library as two independent clones
which were excised from the phage using EcoRI and cloned into pBluescript
(SK) (Simpson et al., 1997). From the sequence of the clones a unique HindIII
site was identified which made it possible for the two clones to be pieced
together.
Construction of b 3A and s 3A GST fusion proteins
To generate antisera to b 3A and s 3A regions of theses proteins were
expressed as GST fusion proteins. The hinge region of b 3A and the C-
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terminal portion of s 3A were isolated by PCR and the resulting products
cloned into pGEX3X using sites engineered into the PCR products (see tables
2.1 and 2.3 showing the sites used).
Table 2.3 Constructs
cDNA Sites used Vector
s 3A C terminus
aa 112-192
BamHI/EcoRI pGEX3X bacterial expression vector
b 3A hinge
aa 644-814
BamHI/SmaI pGEX3X                    "
b 3A NotI/XhoI pMEP mammalian expression vector
b 3A NotI/XhoI pCEP                         "
b 3B *NheI/SpeI/
ClaI/BamHI
pMEP                      "
d XhoI/BamHI pMEP                      "
d XhoI/BamHI pCEP                         "
The cloning of b 3B into pMEP destroyed the NheI and BamHI sites of the
vector.
2.4 Tissue Culture and Transfections
General tissue culture
NRK (normal rat kidney), HeLa, MDBK (Madin-Darby bovine kidney), COS-7,
mocha (mh) (generated during this study), pearl (pe) (Zhen et al., 1999) and
primary mouse cells were grown in Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% fetal calf serum, 50IU/ml penicillin, 50m g/ml
streptomycin, and 2mM L-glutamine at 37°C in a 5% CO2 humidified incubator
(reagents obtained from Sigma). Melan-a cells were grown in RPMI 1640
(Roswell Park Memorial Institute) with the same additions as above, except
200nM teradecanoyl phorbol acetate (TPA) was added and the cells were
maintained in 10% CO2 incubator.
Generation of cell lines
Primary fibroblasts were generated by taking tissue from 1-3 day old mice and
physically disrupting the tissue using a scalpel blade or a pair of scissors. The
36
disrupted tissue was transferred in to DMEM supplemented with 10% fetal calf
serum, 50IU/ml penicillin, 50 m g/ml streptomycin, 2mM L-glutamine and
mercaptoethanol (final concentration 52 m M). After 3-7 days the medium was
changed on the cells. Once cells had grown out from the disrupted tissue the
cells were either frozen or allowed to grow until their growth rates slowed. The
cells had their media supplemented with 200nM TPA. In some cases the cells
changed from slow growth to fast non-contact inhibited growth. The fast
growing cells were cloned by their ability to out grow the rest of the slow
growing cells in the flask.
Transient and Stable Transfections
Several transfection reagents were used during this study, Fugene
(Boehringer Manheim), Superfect (Invitrogen), Calcium Phosphate
(Promega), Lipofectamine (GibCo). All of the procedures were carried out as
described in the manufactures instructions. DNA for transfection was
prepared as described in general molecular biology methods 2.2.
Table 2.4 lists which methods proved most successful for the cell types tried
during this study. Transfection efficiency was estimated by transfecting cells
with a control construct pcDNA3 b -Galactocidase. b -Galactocidase activity
was detected by staining the cells with X-gal as described by the
manufacturers instructions.
Table 2.4 Transfection methods
Cell type Method of transfection Approximate transfection
efficiency % of cells
transfected
NRK Fugene and Lipofectamine  10
COS Fugene, Superfect and
Lipofectamine
 50
HELA Superfect  50
mh Fugene and Calcium
Phosphate
 10*
pe S u p e r f e c t  a n d
Lipofectamine
 1-2
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*Initially up to 10% of the mh cells could be transfected, as the passage
number of the mh cells increased the ability to transfect decreased to levels
similar to that of pe cells.
For the generation of stably transfected cells the cells were transfected as
above with pMEP or pCEP based constructs. The stably transfected cells
were then selected by growing them in DMEM supplemented as above except
hygromycin (0.22mg/ml) (Boehringer Mannheim) was added to the media.
2.5 Antibody Production
Purification of soluble fusion proteins
An overnight culture of MC1061 or DH5 a cells containing either b 3A or s 3A
pGEX3X construct was diluted 1:10 into 2TY and grown for 1 hour at 37°C.
The cells were induced to express fusion protein by the addition of 0.1M IPTG
(final concentration of 0.1mM IPTG) (Sigma). The cells were grown for a
further 5-7 hours and pelleted by spinning for 15 minutes at 4500 rpm. The
cell pellet was resuspended in 1/100 volume of ice cold PBS. The cells were
frozen (-20°C) and then thawed before being sonicated to disrupt the cell
walls. The disrupted cells were incubated for 10 minutes on ice in the
presence of Triton X-100 (final concentration 1%). The cell debris was
pelleted by spinning for 5 minutes at 13000rpm in a bench top microfuge at
4°C. The supernatant was then transferred to an appropriate amount of PBS-
washed glutathione-Sepharose (Pharmacia) and incubated for 20 minutes at
room temperature. The beads were washed 3 times with ice cold PBS and
then washed a further 3 times in ice cold PBS with 10 minute incubation
periods. The fusion protein was eluted from the beads by incubating them for
~5 minutes at room temperature in 50mM Tris-HCl containing 10mM
glutathione. This elution procedure was then repeated a further 3 times and
the eluted protein analysed by SDS-PAGE.
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Fusion protein injection and serum collection
For each fusion protein construct two rabbits were subcutaneously injected
along the flank with 0.5mg of fusion protein. For the first injections the fusion
protein was mixed with Freund’s complete adjuvant (Difco) and subsequently
was mixed with Freund’s incomplete adjuvant (2 and 6 weeks after the initial
injection). 10 days after the final injection the rabbits were terminally bled and
the serum collected and allowed to clot at 37°C for 1 hour. The clot was
removed by spinning at 300 rpm for 5 minutes.
Coupling of fusion protein to Sepharose
The fusion proteins to be coupled were dialysed overnight in coupling buffer
(0.1M NaCHO3 pH 8.3) The dialysed fusion proteins (2mg/ml) were incubated
for 2 hours at room temperature with cyanogen bromide-Sepharose (1ml of
packed beads) (Pharmacia), which had been activated by washing with 1mM
HCl. The beads were washed once with coupling buffer and then washed with
0.1 M Tris-HCl pH 8.0 to quench the activated cyanogen bromide Sepharose.
The beads were washed in 0.1M NaAc pH 4.0 containing 0.5M NaCl and then
in 0.1M Tris-HCl pH 8.0 with 0.5M NaCl. This was repeated a further two
times before the beads were washed once in 200mM glycine pH2.3 and then
three times in PBS containing 0.02% sodium azide.
Affinity purification
10ml of serum was incubated overnight at 4°C with GST-Sepharose (2mg/ml)
in order to remove antibodies raised against GST. The GST-Sepharose was
removed by centrifugation and the supernatant incubated with the appropriate
fusion protein bound to Sepharose beads for at least 1 hour at room
temperature. The Sepharose beads were washed five times with PBS before
being transferred into a chromatography column (BioRad) at 4°C. The bound
antibodies were eluted from the column with 5.5ml of cold 0.2M glycine pH 2.3
containing 0.1% gelatine. The elute was collected into a tube containing 2M
Tris-HCl pH 8.0 and then dialysed overnight in PBS containing 0.02% sodium
azide. To ensure that all of the GST reactive antibodies were removed the
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sample was incubated a further time with GST-Sepharose for 1 hour before
freezing the antibodies at -80°C.
2.6 Immunofluorescence
Cells were grown on multi-well slides (ICN) and fixed by placing in -20°C
methanol for 5 minutes and then in -20°C acetone for 30 seconds before
allowing the slides to air-dry at room temperature. The slides were incubated
in primary antibody(s)  (table 2.2) diluted in 1mg/ml BSA PBS for 30 minutes,
then washed five times in 1mg/ml BSA PBS. The slides were incubated with
secondary antibody(s) (table 2.2) for 30 minutes and then washed as before.
The slides were mounted in 100mg/L p-phenylenediamine adjusted to pH8.0
with 0.5M NaHCO3 in 90% glycerol. Images were captured either using a
BioRad MRC 1000 confocal microscope or a Zeiss Axioplan microscope fitted
with a MicroMax 1300 cooled CCD camera (Princeton Instruments).
2.7 SDS-PAGE
Samples to be analysed by SDS-PAGE (Laemmli, 1970) were boiled in 1x
sample buffer (4x sample buffer is 0.5M Tris-HCl pH 6.5, 8% SDS and 40%
glycerol) containing 5% b -mercaptoethanol for 5 minutes. The samples were
then resolved on mini-gels 10cm x 6cm and 0.5mm thick at a constant voltage
of 140V. The stacking gel used was 50mM Tris-HCl pH 6.8 with 4%
acrylamide and the separating gel used was 1.26M Tris-HCl pH 8.9 with a
varying percentage of acrylamide (6.5-12%).
2.8 Western Blotting
Proteins were transferred onto nitrocellulose (Schleicher and Schuell) by
electroblotting overnight at a constant current of 100mA using a wet blotting
method (Towbin et al., 1979). The buffer used was 50mM Tris-HCl, 0.4M
glycine, 0.1% SDS and 20% methanol. To check protein transfer and to
visualise the molecular weight markers the nitrocellulose was stained with
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Ponceau S in (0.1% TCA) The nitrocellulose was blocked for 1 hour at room
temperature in 50mM Tris-HCl pH7.4, 150mM NaCl, 5mM EDTA, 0.25% w/v
gelatine, 0.1% v/v NP40 and 0.1% NaN3 (blocking buffer). The blot was then
incubated with the appropriate antibody(s) diluted in blocking buffer (see table
2.2) for 30 minutes at room temperature before being washed 3 times quickly
and 3 times slowly (10 minutes per wash) in blocking buffer. The antibodies
were detected by incubating the blot with 125I-protein-A (Amersham) diluted
1/1000 in blocking buffer (0.1 m Ci/ml) for 30 minutes before being washed as
before. The blot was allowed to dry before being exposed to X-ray film or
analysis on a phosphor-imager (Fuji Bas2000 Bio-Imaging Analyser).
2.9 Immunoprecipitations
Immunoprecipitations from tissue culture cells
A semi confluent 75cm2 flask of cells was washed with 10mls of room
temperature PBS, the PBS was aspirated and the cells drained on ice for 5
minutes. The cells were lysed with the addition of 1ml of NP-40 lysis buffer
(150mM NaCl, 1% NP40 and 50mM Tris-HCl pH 7.5 plus protease inhibitor
cocktail (Boehringer Mannheim)) for 10 minutes at 4°C. The cells were
scraped on ice and the lysate cleared by centrifugation at 13000rpm in a
bench top centrifuge for 15 minutes at 4°C (Harlow and Lane, 1988). For
some experiments the cleared lysate was converted to more denaturing
conditions by the addition of SDS (final sample concentration of 0.4%SDS).
The sample was pre-cleared for 30 minutes at 4°C by the addition of 50 m l of
50% slurry of protein-A Sepharose (Sigma). The protein-A Sepharose was
pelleted by spinning at 13000rpm in a bench top centrifuge for 1minute at 4°C.
The supernatant was transferred to a fresh tube and incubated with antibody
(see table 2.2) for 1 hour at 4°C. The antigen-antibody complexes were
captured by the addition of 30 m l of 50% protein-A Sepharose slurry for 1hour
at 4°C. The protein-A Sepharose was peleted as before and washed 3 times
quickly and then 4 times slowly (10 minutes at 4°C) in lysis buffer. The
proteins were eluted from the beads by boiling in 50m l 1x sample buffer for 5
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minutes at 100°C. The samples were analysed by SDS-PAGE as described in
2.6 and Western blotted as described in 2.7.
Immunoprecipitations from tissue samples
Tissue samples were homogenised in 3-4 volumes of PBS 1% NP40 or lysis
buffer in a Teflon/ glass homogeniser using  ~ 20 stokes. The homogenate
was clarified by spinning at 100,000rpm for 15 minutes in a TL 100.3 rotor
(Optima TLX ultracentrifuge Beckman Instruments). The supernatant was
processed as above.
2.10 [32P] orthophosphate  labelling of tissue culture cells
Cells to be labelled were grown in a 150cm2 tissue culture dish until they
reached 80-90% confluency. The cells were washed with phosphate free
media (DMEM) prior to labelling. The cells were labelled for 3 hours using
1mCi of [32P] orthophosphate in 10ml of phosphate free DMEM. The labelling
was terminated by removing the labelling media and washing the cells with ice
cold DMEM three times. The cells were detergent extracted as in section 2.8
except the extraction buffer was supplemented with 1mM Na3Vo4 to inhibit
phosphatases. Immunoprecipitations were performed from the detergent
extract as previously described section 2.8.
2.11 Missorting assay
Qualitative missorting assay
mh cells were transiently transfected overnight with DNA encoding the delta
subunit of the AP-3 complex, using the lipid based transfection reagent
Fugene as described by the manufactures instructions. The expression
vectors used were either pCEP- d  or pMEP- d . The next day the cells were
passaged onto glass mullti-well slides. If the expression vector used was
pMEP the cells were induced with the addition of 2 m M cadmium.
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The next day the cells were washed in 37°C DMEM and then incubated with
antibodies against anti-LAMPI or CD44 diluted in DMEM for 6-7 hours (see
antibodies table 2.2). In some experiments Alexa 350 wheat germ lectin
(20 m g/ml) was added to the incubation media in addition to the antibodies.
The cells were washed six times with ice cold DMEM and fixed in –20°C
methanol/acetone (if the cells were incubated in the presence of wheat germ
lectin the DMEM used for washing the cells was supplemented with 50mM N-
Acetyl-D-glucosamine to remove surface bound lectin). The cells were stained
with an anti-delta antibody. The anti-delta antibody and endocytosed
antibodies were visualised using fluorescently labelled secondary antibodies
(see antibodies table 2.2). Images were captured either using a BioRad MRC
1000 confocal microscope or a Zeiss Axioplan microscope fitted with a
MicroMax 1300 cooled CCD camera.
Quantitative missorting assay
pe cell stably transfected with b3 B cDNA were passaged onto 24 well dishes
and grown overnight (semi-confluent T75cm2 flask for four multi-well dishes).
The next day the cells were washed in 37°C DMEM and then incubated for 6-
7 hours with rat anti-LAMP and CD44 antibodies diluted in DMEM (1/100).
The cells were washed six times with ice cold DMEM, and fixed in –20°C
methanol.
The cells were blocked in 1mg/ml BSA PBS (blocking solution) for 5 minutes,
before being incubated with anti-rat or anti-Texas red antibodies for 30
minutes at room temperature (diluted 1/1000 in blocking solution). The cells
were washed 3 times with blocking solution and then washed a further 3 times
in blocking solution with 10 minute incubation periods. The cells were then
incubated for 30 minutes with 125I-Protein A (Amersham) at room temperature
(diluted 1/2000 in blocking solution). The cells were washed 3 times with
blocking solution and then washed a further 3 times in blocking solution with
10 minute incubation periods. The blocking solution was then removed and
the cells extracted in 200m l of 1M NaOH for 1 minute. The extracted cells
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were then transferred to 2ml eppendorf tubes and the amount 125I-Protein A
bound counted in a g counter for 1 minute.
ApaI 1813
HindIII 1499
KasI 1024
NotI 894BamHI 391
C1 C2 C3 C4
PCR product
b3B
C1
C2
C3 C4
(a)
(b)
Figure 2.1
Diagram showing the aligment of b3B to the ESTs obtained from the Image consortium 
(a) and how b3B was assembled from the partial ESTs (b).
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Chapter 3
The identification and cloning of the ubiquitously expressed isoform of
b 3B
3.1 Introduction
At the time this work was begun, a study by Simpson et al.  (1996) had shown
that p47 ( m 3) and b -NAP ( b 3B) are components of a novel adaptor-like
complex associated with two unknown proteins of 160kD and 25kD (Fig.
3.1)(Simpson et al., 1996). It seemed likely that the 160kD protein would
share homology with a  and g  adaptin and the 25kD protein would share
homology with the s 1 and s 2 small chains, given that b 3B shares homology
with b 1 and b 2 adaptins and m 3A/ m 3B with m 1 and m 2 medium subunits
(Simpson et al., 1996). To identify the missing subunits of the adaptor-like
complex the expressed sequence tags database (EST) was searched for
clones that had homology to a  and g adaptins and s 1 and s 2 small chains.
The EST database was also searched for a ubiquitously expressed
homologue of b 3B. The reason for searching the EST database for a
ubiquitously expressed isoform of b 3B is there are two isoforms of m 3, one
ubiquitous (m 3A) and one neuronal specific ( m 3B) suggesting there is a
ubiquitously expressed form of this adaptor-like complex. Five clones were
identified and obtained from the IMAGE Consortium. Two clones had
homology to the C-terminal portions of s 1 and s 2 and were approximately
80% identical to each other. The two sigma-like clones were isolated from
human placenta and brain tissue (GenBank R23892 and R87391). One clone
had homology to the N-terminal portions of a  and g  and was isolated from
human uterus tissue (GenBank T30164). Two clones had homology to the C-
terminal region of b 3B and were isolated from human liver and spleen tissue
(GenBank R02669 and T98538). The s -like ESTs were cloned by Dr Margaret
S. Robinson and the a / g - like EST were cloned and fully sequenced by Lina
Christopoulou under my supervision (Simpson et al., 1997). The a /g -like
molecule was named d  and is ~15% identical to a  and g . The two s -like
molecules were named s 3A and s 3B and are ~84% identical to each other
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and ~30% identical to s 1 and s 2. Multiple tissue Northern blots were probed
using radiolabelled oligonucleotides corresponding to selected regions of d ,
s 3A and s 3B; all three adaptor-like subunits were ubiquitously expressed
(Simpson et al., 1997).
To investigate if the two ESTs that had homology to b 3B encoded the same
protein a multiple tissue Northern blot (Clontech) was probed sequentially with
the two radiolabelled ESTs. Both ESTs bound a band of approximately the
same size (4.4kb) on the Northern blot suggesting that they did encode the
same protein (unpublished observations Fiona Simpson). The band that was
recognised by the probes was present in all tissues on the Northern blot
indicating that the isoform of b 3B was ubiquitously expressed like m 3A,
s 3A/ s 3B and d,  suggesting that there is a ubiquitously expressed form of this
complex (Simpson et al., 1997). From partial sequencing and restriction
digests of the ESTs, it became apparent that the ESTs could not encode the
full-length b 3B so a library screen would have to be carried out to obtain the
full-length clone (Fig. 3.2).
3.2 Cloning of the ubiquitously expressed isoform of b 3B
To obtain a full-length clone encoding the ubiquitously expressed isoform of
b 3B a human heart cDNA l gt10 phage library was screened by probing
duplicate filters using either radiolabelled R02669 or T98538 ESTs (described
in Materials and Methods section 2.2). The library was screened using the two
ESTs to increase the chances of a full-length clone being isolated. Using the
above strategy nine clones were plaque purified and the DNA isolated from
the phage. The isolated phage DNA was digested with EcoRI to recover the
cDNA inserts. Out of the nine clones only three of the clones bound both
probes, clones 1, 2 and 3, suggesting they might be full-length (Fig. 3.3).
Clone 3 has an internal EcoRI site. Clone 3 was chosen for further analysis as
when the two EcoRI fragments were added together they give a clone of
~3.5kb which is potentially large enough to encode the full-length b 3B
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homologue ( b 3B is encoded by ~3.3kb of DNA). The two clone 3 fragments
were cloned into the EcoRI site of pBluescript (SK).
3.3 Sequencing and contig assembly
The two pBluescript clones were partially sequenced (described in Materials
and Methods 2.2) using T3 and T7 to confirm that they encoded the b 3B
homologue. When it was confirmed that the 2 clones did encode the b 3B
homologue the clones were digested into 6 fragments and subcloned into
pBluescript (SK). The fragments were sequenced as above using T3 and T7.
From the sequence obtained a partial contig was assembled and the
sequence used to design internal sequencing primers. From the final
sequencing data a contig was assembled for the b 3B isoform with complete
agreement from both directions of sequencing.
The assembled contig contained 1 large predicted open reading frame (ORF)
encoding a protein of 1093aa with a conserved Kozak sequence 5' to the start
methione and several stop codons in all three reading frames 3' to the first
stop codon (Kozak, 1987). To confirm that the correct ORF had been
identified the protein sequence was compared to b 1, b 2 and b 3B protein
sequences (Fig. 3.4) (corrected b 3B sequence was used for alignment; see
section 3.5). The strong alignment with the homologues suggested that the
correct ORF had been identified. In line with the adaptor nomenclature the
newly cloned isoform was named b 3A (the (A) stands for ubiquitous
expression as with m 3A), GenBank accession number U91931.
3.4 Sequence comparison and hydropathy plots
The b 3A and b 3B are very similar with the b 3A being 11 amino acids longer
than b 3B (Fig. 3.4). The main region of divergence between b 3A and b 3B is in
the hinge region of the molecule, most clearly shown by a diagon plot (Fig.
3.5). b 3A is related to b 1 (21.6% identical) and b 2 (21.4% identical) but is
more homologous to b 3B (62.1% identical) particularly in the N-terminals and
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C-terminal domains. The homology between b 3A, b 1 and b 2 is mainly
restricted to the N-terminal domains of the proteins (Fig. 3.5). Like the other
adaptins ( a , g  and b )  b 3A contains the consensus sequences WIIGEY
(WLIGEN) (Simpson et al., 1997) and KKLVY in its N-terminal portion (Fig.
3.4). The function of these conserved motifs is still unknown. b 3A like other
adaptins has a 3 domain structure consisting of an N-terminal domain of ~600
amino acids, a hinge domain (normally rich in acidic residues and prolines)
and C-terminal ear domain. The hinge domains of b 3A and b 3B are very rich
in acidic amino acids (D/E) and serine residues (Fig. 3.4). The very polar
nature of the hinge region in b 3A and b 3B is most clearly shown by a
hydropathy plot (Fig. 3.6) (Kyte and Doolittle, 1982). The hydropathy plots
show that b 3A and b 3B have very hydrophilic hinge domains compared to b 1
and b 2 hinge domains. All of the beta subunits have several serine residues
that could be potentially sites for casein kinase phosphorylation, and b 3A and
b 3B have a very large number of these sites in the hydrophilic hinge region
(Mercier, 1981) (Fig. 3.4).
3.5 Cloning of b 3B
The group that cloned b 3B (Newman et al., 1995) were unwilling to give
access to the published b 3B cDNA, so the EST database was searched for
clones that could encode b 3B. Several clones (GenBank 175331, 231345,
320375 and 165789) were isolated and a cloning strategy was designed to
piece these ESTs together to make a full-length clone (Materials and Methods
section 2.3 and Fig. 2.1). Part way through the cloning of b 3B one of the sub
cloning steps failed; further examination of the problem revealed that the
predicted ApaI site at 1024bp was not present in the EST (GenBank 320375)
(Newman et al., 1995). The EST was sequenced in both directions and did
not contain an ApaI site but a KasI site at 1024bp. When the EST database
was searched using the ESTs sequence several clones were identified and
none of them contained an ApaI site at 1024bp confirming the sequence and
suggesting there may be a sequencing error in original b 3B clone. When the
ESTs DNA sequence was compared to b 3A and the published b 3B DNA
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sequences it is apparent that the published b 3B DNA sequence contains 3
frame shifts starting at the predicted ApaI site (Fig. 3.7). The three frame
shifts cause 14 amino acids in the region to be incorrect. When the protein
sequence of the corrected b 3B is compared to the sequence of b 3A the two
proteins are now more similar in the corrected region (Fig. 3.7). The corrected
b 3B sequence has the GenBank accession number AF022152.
b 3B
m 3
p160
p25
Figure 3.1
Diagram representing the proposed subunit composition of the adaptor-related complex. 
p160  is expected to have homology to a  and g  and p25 is expected to have 
homology to s 1 and s 2.
b 3B
EST (b)  EST (a)
Figure 3.2
Diagram showing the alignment of b 3B to the ubiquitously expressed GenBank clones
R02669 (a) and T98538 (b).
1 2 3 4 5 6 7 8Kb
0.5
4.3
2.0
.
.
.
a
b
c
Figure 3.3
To obtain a full-length clone encoding the ubiquitously expressed isoform of b 3B a
human heart cDNA library was screened using the R02669 and T98538 ESTs as
described in Materials and Methods 2.2. The (b) EST was excised from its vector
using EcoRI and PacI, the (a) EST was isolated by PCR using T3 and T7 primers
as the insert contained an internal EcoRI restriction site. The ESTs were
radiolabelled as in Materials and Methods 2.2. The isolated phage were digested
with EcoRI and run on a 1% agarose gel (panel a). The DNA was transferred to
nylon membranes and then probed with either the R02669 EST (panel b) or the
T98538 EST (panel c).
M T D S K Y - F T T T K K G E - - - - - - - - - - - - - - - - - - - - I F - - -b1
M T D S K Y - F T T N K K G E - - - - - - - - - - - - - - - - - - - - I F - - -b2
M S S N S F P Y N E Q S G G G E A T E L G Q E A T S T I S P S G A F G L F S S Db3A
M S A A P - A Y S E D K G G S A G P - - G E P E Y G H D P A S G - - G I F S S Db3B
- - - - - E L K A E L N S D K K E K K K E A V K K V I A S M T V G K D V S A L Fb1
- - - - - E L K A E L N N E K K E K R K E A V K K V I A A M T V G K D V S S L Fb2
L K K N E D L K Q M L E S N K D S A K L D A M K R I V G M I A K G K N A S E L Fb3A
Y K R H D D L K E M L D T N K D S L K L E A M K R I V A M I A R G K N A S D L Fb3B
P D V V N C M Q T D N L E L K K L V Y L Y L M N Y A K S Q P D M A I M A V N T Fb1
P D V V N C M Q T D N L E L K K L V Y L Y L M N Y A K S Q P D M A I M A V N S Fb2
P A V V K N V A S K N I E I K K L V Y V Y L V R Y A E E Q Q D L A L L S I S T Fb3A
P A V V K N V A C K N I E V K K L V Y V Y L V R Y A E E Q Q D L A L L S I S T Fb3B
V K D C E D P N P L I R A L A V R T M G C I R V D K I T E Y L C E P L R K C L Kb1
V K D C E D P N P L I R A L A V R T M G C I R V D K I T E Y L C E P L R K C L Kb2
Q R A L K D P N Q L I R A S A L R V L S S I R V P I I V P I M M L A I K E A S Ab3A
Q R G L K D P N Q L I R A S A L R V L S S I R V P I I V P I M M L A I K E A A Sb3B
D E D P Y V R K T A A V C V A K L H D I N A Q L V E D Q G F L D T L K D L I S Db1
D E D P Y V R K T A A V C V A K L H D I N A Q M V E D Q G F L D S L R D L I A Db2
D L S P Y V R K N A A H A I Q K L Y S L D P E - - Q K E M L I E V I E K L L K Db3A
D M S P Y V R K T A A H A I P K L Y S L D S D - - Q K D Q L I E V I E K L L A Db3B
S N P M V V A N A V A A L S E I A E S H P S S N L L D L N P Q S I N K L L T A Lb1
S N P M V V A N A V A A L S E I S E S H P N S N L L D L N P Q N I N K L L T A Lb2
K S T L V A G S V V M A F E E V C P D R - - - - - I D L I H K N Y R K L C N L Lb3A
K T T L V A G S V V M A F E E V C P E R - - - - - I D L I H K N Y R K L C N L Lb3B
N E C T E W G Q I F I L D C L A N Y M P K - - - - - - - - - - - - - - - - - - -b1
N E C T E W G Q I F I L D C L S N Y N P K - - - - - - - - - - - - - - - - - - -b2
V D V E E W G Q V V I I H M L T R Y A R T Q F V S P W K E G D E L E D N G - K Nb3A
I D V E E W G Q V V I I S M L T R Y A R T Q F L S P T Q N E S L L E E N A E K Ab3B
- - - - D D R E A Q S I C E R V T - - - - - - - - - P R L S H A N S A V V L S Ab1
- - - - D D R E A Q S I C E R V T - - - - - - - - - P R L S H A N S A V V L S Ab2
F Y E S D D D Q K E K T D K K - - - - - - - - - K K P Y T M D P D H R L L I R Nb3A
F Y G S E E D E A K G A G S E E T A A A A A P S R K P Y V M D P D H R L L L R Nb3B
V K V L M K F M E - - - M L S K D L D Y Y G T L L K K - - - - L A P P L V T L Lb1
V K V L M K F L E - - - L L P K D S D Y Y N M L L K K - - - - L A P P L V T L Lb2
T K P L L Q S R N A A V V M A V A Q L Y W H I S P K S E A G I I S K S L V R L Lb3A
T K P L L Q S R S A A V V M A V A Q L Y F H L A P K A E V G V I A K A L V R L Lb3B
S A E P E L Q Y V A L R N I N L I V Q K R P E I L K H E M K V F F V K Y N D P Ib1
S G E P E V Q Y V A L R N I N L I V Q K R P E I L K Q E I K V F F V K Y N D P Ib2
R S N R E V Q Y I V L Q N I A T M S I Q R K G M F E P Y L K S F Y V R S T D P Tb3A
R S H S E V Q Y V V L Q N V A T M S I K R R G M F E P Y L K S F Y I R S T D P Tb3B
Y V K L E K L D I M I R L A S Q A N I A Q V L A E L K E Y A T E V D V D F V R Kb1
Y V K L E K L D I M I R L A S Q A N I A Q V L A E L K E Y A T E V D V D F V R Kb2
M I K T L K L E I L T N L A N E A N I S T L L R E F Q T Y V K S Q D K Q F A A Ab3A
Q I K I L K L E V L T N L A N E T N I P T V L R E F Q T Y I R S M D K D F V A Ab3B
A V R A I G R C A I K V E Q S A E R C V S T L L D L I Q T K V N Y V V Q E A I Vb1
A V R A I G R C A I K V E Q S A E R C V S T L L D L I Q T K V N Y V V Q E A I Vb2
T I Q T I G R C A T N I L E V T D T C L N G L V C L L S N R D E I V V A E S V Vb3A
T I Q A I G R C A T N I G R V R D T C L N G L V Q L L S N R D E L V V A E S V Vb3B
F L K K P T E T Q E L V Q Q V L S L A T Q D S D N P D L R D R G Y I Y W R L L Sb1
F L K K P S E T Q E L V Q Q V L S L A T Q D S D N P D L R D R G Y I Y W R L L Sb2
Y L T N S K Q T K L L T Q Y I L N L G K Y D - Q N Y D I R D R T R F I R Q L I Vb3A
Y L T N S K Q T K L L T Q Y V L S L A K Y D - Q N Y D I R D R A R F T R Q L I Vb3B
T D P V A - - - - - - A K E V V L A E K P L I S E E T D L I E P T L - - L D E Lb1
T D P V T - - - - - - A K E V V L S E K P L I S E E T D L I E P T L - - L D E Lb2
P N E K S G A L S K Y A K K I F L A Q K P A P L L E S P F K D R D H F Q L G T Lb3A
P S E Q G G A L S R H A K K L F L A P K P A P V L E S S F K D R D H F Q L G S Lb3B
I C Y I G T L A S V Y H K P P S - - - - - - - - - - - - - - - - - - - - - - - -b1
I C H I G S L A S V Y H K P P N - - - - - - - - - - - - - - - - - - - - - - - -b2
S H T L N I K A T G Y L E L S N W P E V A P D P S V R N V E V I E L A K E W T Pb3A
S H L L N A K A T G Y Q E L P D W P E E A P D P S V R N V E V - - - - P E W T Kb3B
- - - - - - - - - - - - A F - - - - - V E G G R G V V H K S L P P R T A S S E Sb1
- - - - - - - - - - - - A F - - - - - V E G S H G I H R K H L P I H H G S T D Ab2
- A G K A K Q E N S A K K F Y S E S E E E E D S S D S S - S D S E S E S G S E Sb3A
C S N R E K R K E K E K P F Y S D S E G E S G P T E S A D S D P E S E S E S D Sb3B
V I K D I F R K Y P N K Y E S V I A T L C E N L D S L D E P E A R A A M I W I Vb1
V I R D I F R K Y P N K Y E S I I A T L C E N L D S L D E P D A R A A M I W I Vb2
V I K K L L Q M Q P A Q H G E I I K H M A K L L D S I T V P V A R A S I L W L Ib3A
V I K K L L Q M Q P A Q H G E I I K H L A K L T D N I Q V P M A R A S I L W L Ib3B
G E Y A E R I D N - A D E L L E S F L E G F H D E S T Q V Q L Q L L T A I V K Lb1
G E Y A E R I D N - A D E L L E S F L E G F H D E S T Q V Q L T L L T A I V K Lb2
G E N C E R V P K I A P D V L R K M A K S F T S E D D L V K L Q I L N L G A K Lb3A
G E Y C E H V P R I A P D V L R K M A K S F T A E E D I V K L Q V I N L A A K Lb3B
_________
_________
_________
T - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -b1
T - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -b2
D S E S E S E P E S E S E S R R V T K E K E K T K Q D R T P L T K D V S L L D Lb3A
E S E M T S E S E E E Q L E P A S W S R K T P P S S K S A P A T K E I S L L D Lb3B
- N F V A P P T A A V - - P A N L G A P I G S G L S D L F D L T S G - - - V G Tb1
- - F A P S P T P A V - - - - - - - - - V S S G L N D L F E L S T G - - - I G Mb2
D D F N P V S T P V A L P T P A L S P S L M A D L E G L - H L S T S S S V I S Vb3A
E F T P P S V Q P V S P P A I V S T S L A A D L E G L - T L T D S T L V P S Lb3B
L S G S Y V A P K A - V W L P A M K A K G L E I S G T F T R Q V G S - - - - - Ib1
A P G G Y V A P K A - V W L P A V K A K G L E I S G T F T H R Q G H - - - - - Ib2
S T P A F V P T K T H V L L H R M S G K G L A A H Y F F P R Q P C I F G D K M Vb3A
L S P V S G V G R - Q E L L H R V A G E G L A V D Y T F S R Q P F S G D P H M Vb3B
S M D L Q L T N K A L Q V M T D F A I Q F N R N S F G L A P A A P L Q V H A P Lb1
Y M E M N F T N K A L Q H M T D F A I Q F N K N S F G V I P S T P L A I H T P Lb2
S I Q I T L N N T T D R K I E N I H I G E K K L P I G M K - M H V F N P I D S Lb3A
S V H I H F S N S S D T P I K G L H V G T P K L P A G I S - I Q E F P E I E S Lb3B
S P N Q T V E I S L P L S T V G S V M K M E P L N N L Q V A V K N N I D V F Y Fb1
M P N Q S I D V S L P L N T L G P V M K M E P L N N L Q V A V K N N I D V F Y Fb2
E P E G S I T V S M G I D F C D S T Q T - - - - A S F Q L C T K D - - D C F N Vb3A
A P G E S A T A V M G I N F C D S T Q A - - - - A N F Q L C T Q T - - R Q F Y Vb3B
S T L Y P L H I L F V - - - - - - E D G K M D R Q M F L A T W K D I P N E N E Ab1
S C L I P L N V L F V - - - - - - E D G K M E R Q V F L A T W K D I P N E N E Lb2
N I Q P P V G E L L L P V A M S E K D F K K E Q G V L T G M - - - - - N E T S Ab3A
S I Q P P V G E L M A P V F M S E N E F K K E Q G K L M G M - - - - - N E I T Eb3B
Q F Q I R D C P L N A E A A S S K L Q S S N I F T V A K R N V E G Q D M L Y Q Sb1
Q F Q I K E C H L N A D T V S S K L Q N N N V Y T I A K R N V E G Q D M L Y Q Sb2
V I I A A P Q N F T P S V I F Q K V V N V A N V G A V - P S G Q D N I H R F A Ab3A
K L M L P D T C R S D H I V V Q K V T A T A N L G R V - P C G T S D E Y R F A Gb3B
L K L T N G I W V L A E L R I Q P G N P S C T                  b1
L K L T N G I W I L A E L R I Q P G N P N Y T L S L K C R A P E V S Q Y I Y Q Vb2
K T V H S G S L M L V T V E L K E G S T A - Q L I I N T E K T V I G S V L L R Eb3A
R T L T G G S L V L L T L D A R P A G A A - Q L T V N S E K M V I G T M L V K Db3B
                                        b1
Y D S I L K N                                b2
L K P V L S Q G                                  b3A
V I Q A L T Q                                  b3B
Figure 3.4
Protein sequence alignment  of b1, b2, b3A and  b3B;   identical  residues   are boxed. 
Potential serine phosphorylation sites are bold (S). Conserved consensus sequences 
are underlined (_). The hinge region of b3A and b3B is shaded (    ).
A E S P E T A P T G A P P G E Q P D V I P A Q G D L L - - - - G D L L N L D L Gb1
G D S P - V G T T T A T N L E Q P Q V I P S Q G D L L - - - - G D L L N L D L Gb2
G E Q G E S G E E G D S N E D S S E D S S S E Q D S E S G R E S G L E N K R T Ab3A
K S S S E S G S G E S S S E S D N E D Q D E D E E K G R G S E S E - Q S E E D Gb3B
P P V S G P P L A T S S V Q M G A V D L L G G G L D S L M G D E - - P E G I G Gb1
P P V N V P Q V - - S S M Q M G A V D L L G G G L D S L V G Q S F I P S S V P Ab2
K R N S K A K G K S D S E D G E K E N E K S K T S D S S N D E S S S I E D S S Sb3A
K R K T K K K V P E - - - - - - - - - - - R K G E A S S S D E G S D S S S S S Sb3B
D
b 1
b 2
b 2
b 3A b 3A
b 3B
b 1
b 3A
82.9% 21.6%
62.1%21.4%
Figure 3.5
A series of Diagon plots comparing the protein sequence of b 3A to b 1, b 2 and b 3B. 
The greater the similarity between proteins the stronger the diagonal line.
b 1
b 2
b 3A
b 3B
Figure 3.6
A series of hydropathy plots calculated from the protein sequences of b 1, b 2, b 3A 
and b 3B. A negative hydropathy index indicates a hydrophilic region in the protein.
G T G A T G G C G G T G G C G C A G C T C T A C T T C C A Cb3B
G T G A T G G C G G T G G C G C A G C T C T A C T T C C A Cb3B*
G T T A T G G C A G T T G C T C A G C T G T A T T G G C A Cb3A
C T G G - G C C C A A G G C G G A A G T G G - C G T C A T C
C T G G C G C C C A A G G C G G A A G T G G G C G T C A T C
A T A T C A C C A A A A T C T G A A G C T G G C A T A A T T
G C C A A G G C G C T G G T G C G C - T G C T G C G C A G C
G C C A A G G C G C T G G T G C G C C T G C T G C G C A G C
T C T A A A T C A C T A G T G C G T T T A C T T C G T A G C
V M A V A Q L Y F H L G P R R K W - R H R Q G A G A L L R Sb3B
V M A V A Q L Y F H L A P K A E V G V I A K A L V R L L R Sb3B*
V M A V A Q L Y W H I S P K S E A G I I S K S L V R L L R Sb3A
Figure 3.7
DNA (a) and protein (b) sequence alignment of b3A, corrected b3B (*) and 
published b3B.
a
b
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Chapter 4
Characterisation of the adaptor-related AP-3 complex
4.1 Introduction
To further characterise the newly identified adaptor-like subunits ( d , b 3A s 3A
and s 3B) and to determine if they are associated with the previously
described adaptor-like complex (containing b 3B and m 3), portions of them
were expressed as GST fusion proteins and used to raise polyclonal
antibodies. Antibodies against the N-terminal portion of the d  subunit and the
C-terminal portion of the s 3B subunit were raised by Fiona Simpson. The two
anti- d  affinity-purified sera recognised an antigen of ~160kD on a pig brain
homogenate Western blots. The antigen recognised by the anti- d  antibodies
runs larger than would be predicted from the open reading frame
(ORF)(130kD) for the d  subunit; this is probably due to the large amount of
charged residues in its hinge domain. The anti- s 3B antibodies recognised
several bands on a pig brain homogenate Western blots although both
affinity-purified sera recognised a band of ~21kD, which is approximately the
correct size for s 3B from its predicted ORF (21kD) (Simpson et al., 1997).
I raised antibodies against the hinge domain of the b 3A subunit and the C-
terminal portion of the s 3A subunit. Antibodies were raised against these
domains as they have been proven to be antigenic in the cases of b 1, b 2, s 1
and s 2.
4.2 Characterisation of anti- s 3A and b 3A antibodies
To characterise b 3A and s 3A, antibodies were raised against the hinge
domain (amino acids 644-814) of b 3A and the C-terminal domain (amino
acids 112-192) of s 3A (Materials and Methods sections 2.3 and 2.5). Two
rabbits were injected with each antigen and the affinity purified sera used to
probe pig brain homogenate Western blots. The anti- s 3A antibodies reacted
with several antigens on the Western blot although both sera shared an
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antigen in common at ~21kD which is approximately the correct size for s 3A
from its predicted ORF (21kD)(data not shown). The anti- b 3A sera reacted
with several antigens on the Western blot although both sera shared an
antigen in common at ~120kD which is approximately the correct size for b 3A
from its predicted ORF (121kD) (data not shown).
To confirm that the antigens anti-s 3A and b 3A antibodies recognised on the
Western blots were correct, native immunoprecipitations from big brain tissue
followed by Western blotting were performed (Materials and Methods sections
2.8 and 2.9).  After immunoprecipitation and Western blotting both the anti-
s 3A and b 3A antibodies recognised the same antigens as were previously
recognised from the pig brain homogenate Western blots, confirming that the
s 3A is ~21kD and the b 3A is ~120kD (Fig. 4.1).
4.3 Subunit composition of the adaptor-related complex
To determine if d , b 3A/B, s 3A/B and m 3A/B were all part of the same complex
a series of native immunoprecipitations followed by Western blotting
experiments were performed as in Materials and Methods sections 2.8 and
2.9.  Pig brain samples were immunoprecipitated under native conditions with
antibodies against d , b 3B, s 3A/B (mixture of s 3A and s 3B antibodies were
used for immunoprecipitations and Western blotting) and an anti- g  adaptin
antibody to bring down the AP-1 complex as a control. The reason for using
pig brain tissue was the b 3B antibody is tissue specific. Rat liver was
immunoprecipitated under native conditions with an antibody against b 3A.
Strips were cut from the Western blotted and probed in the appropriate
regions for d , b 3A/B, m 3A/B and s 3A/B ( m 3 antibody recognises both m 3A and
m 3B on a Western blot) (Fig. 4.2).
The anti- b 3B antibody not only brings down b 3B and m 3, as has been
previously reported, but also brings down d  and s 3A/B (which appears as a
doublet, presumably as there are two isoforms). The b 3B IP does not bring
down g  as expected, since g  is a subunit of the AP-1 complex. Similarly the
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anti- d  and s 3A/B antibodies also bring down d , b 3A/B, m 3A/B and s 3A/B and
not g  (the s 3A/B IP is not as strong as the other immunoprecipitations
presumably as only one of the anti- s 3 antibodies immunoprecipitates
strongly). Also as expected the anti-b 3A antibody also brings down d , b 3A,
m 3A and s 3A/B, suggesting that the AP-3 complex is also present in non-
neuronal tissues.
These results indicates that, like a conventional adaptor complex, the adaptor-
like complex consists of a /g  like subunit (d ), a b  subunit, a m  subunit and a s
subunit. We have named the complex AP-3.
4.4 Localisation of the AP-3 complex in non-neuronal cells
Previously the AP-3 complex had been localised by immunoflourescence and
immunogold electron microscopy using antibodies against b 3B. However it
was only possible to localise the complex in neurons or in cells which had
been permeabilised and been incubated in pig brain cytosol (in vitro
recruitment) because of the tissue specificity of the antibodies (Simpson et al.,
1996). With the production of an antibody against the d  subunit of the AP-3
complex by Fiona Simpson, it became possible to localise the endogenous
complex in non-neuronal cells at the level of immunoflourescence.
Primary mouse fibroblast were fixed and stained for the d  subunit of the AP-3
complex (Materials and Methods section 2.6) (Fig. 4.3). The staining pattern is
mainly perinuclear with punctate labelling extending out into the periphery of
the cell. This staining is reminiscent of patterns seen with markers of the
endosomal system, therefore to investigate this further cells were doubled
labelled for d  and markers for the early and late endocytic systems.
NRK cells were allowed to endocytose a monoclonal anti-transferrin receptor
antibody (1/100 in DMEM) for 1 hour. The cells were fixed and stained with
anti- d  (Materials and Methods section 2.6) (Fig 4.4). As the cells were allowed
to endocytose the anti-transferrin receptor antibody for 1 hour the early and
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late endocytic systems have been labelled (Hopkins and Trowbridge, 1983).
There is some staining of d  and the transferrin receptor that coincide in the
perinuclear region of the cell, although there is a large amount of staining that
does not coincide. At this level of resolution it is difficult to tell if the regions
that do coincide are actually colocalised or not. To resolve this question the
study would have to be repeated at the level of immunogold electron
microscopy, unfortunately it was impossible to carry out the immunogold
electron microscopy, as the anti- d  antibodies do not work under the fixation
conditions required.
COS cells were fixed and stained for anti-CD63 and anti- d  antibodies (cells
were processed as in Materials and Methods section 2.6) (Fig.4.5). CD63
mainly is localised to late endocytic structures and lysosomes (Metzelaar et
al., 1991). The two staining patterns do not coincide so suggesting the AP-3
complex is not associated with this compartment.
4.5 The ubiquitously expressed AP-3 complex is not localised or
enriched in rat clathrin-coated vesicles
Previously it had been shown that the AP-3 complex in neuronal cells did not
colocalise with clathrin at the level of immunofluorescence and immunogold
electron microscopy (Simpson et al., 1996). To investigate if this was also the
case for the ubiquitously expressed AP-3 complex, NRK cells were fixed and
stained with antibodies against anti-d  and anti-clathrin heavy chain (processed
as in Materials and Methods section 2.6)(Fig. 4.6). The two patterns look very
similar although there is very limited colocalisation.  The small amount of
colocalisation in the perinuclear region is consistent with earlier observations
using immunogold electron microscopy, which revealed that b 3B and clathrin
were often in close proximity but were on different budding profiles (Simpson
et al., 1996). This result, as with the previous study findings, suggests that the
AP-3 complex is not associated with clathrin.
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The Simpson et al. (1996), study had also shown that the neuronal AP-3
complex was not enriched in pig brain clathrin-coated vesicles (CCV)
(Simpson et al., 1996). To investigate if this was also true for the ubiquitously
expressed AP-3 complex, rat liver homogenate and rat liver CCV and were
Western blotted with anti- s 3A and control s 1 antibodies (rat liver clathrin-
coated vesicles were a gift from Dr M. S. Robinson)(Fig. 4.7). s 1, a subunit of
the AP-1 complex, is detectable in the homogenate and is very highly
enriched in the clathrin-coated vesicles, unlike s 3A which is only detectable in
the liver homogenate. This result suggests that the ubiquitously expressed
AP-3 complex, like the neuronal AP-3 complex, does interact with clathrin in a
manner like AP-1 or AP-2.
4.6 Phosphorylation of the AP-3 complex
It has been previously shown that b 3B, a subunit of the neuronal AP-3
complex is the major target for phosphorylation in the complex (Newman et
al., 1995). Like b 3B, b 3A has many potential casein kinase phosphorylation
sites in its hinge domain. To investigate if b 3A is the major target for
phosphorylation in the ubiquitously expressed AP-3 complex, NRK cells were
labelled for 3 hours with 1mCi of 32P-orthophosphate. The cells were
detergent extracted and immunoprecipitated with antibodies raised against g ,
s 3A, b 3A and d  (g  was used as a control)(Materials and Methods section
2.10). Under the conditions used only one major phosporylated protein at
~120kD was detected in the s 3A, b 3A and d  immunoprecipitations but not in
the g  control immunoprecipitation (Fig. 4.8). The size of the phosporylated
band and its presence only in the anti-AP-3 immunoprecipitation would
suggest that the phospho-protein is the b 3A subunit of the AP-3 complex.
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Figure 4.1
Native immunoprecipitations from pig brain tissue were performed using anti- b 3A
or s 3A antibodies followed by Western blotting with the above antibodies (-
indicates that no antibody was added to the immunoprecipitation and the sample
was only incubated with protein-A Sepharose). Immunoprecipitations and Western
blotting were performed as in Materials and Methods sections 2.8 and 2.9. The
immunoprecipitations indicate that b 3A is ~120kD and s 3A is ~21kD.
Brain Liver
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IP
Figure 4.2
Pig brain samples were immunoprecipitated under native conditions with affinity-
purified polyclonal antibodies against g , s 3A/B, b 3B and d. A rat liver sample was
immunoprecipitated under native conditions with a affinity-purified polyclonal
antibody against b 3A. The samples were subjected to SDS-PAGE and Western
blotted, and the appropriate regions were probed with antibodies against g ,
s 3A/B, b 3A/B and d (the brain immunoprecipitations were blotted with b 3B and
the liver immunoprecipitation blotted with b 3A). Western blots and
immunoprecipitations were performed as in Materials and Methods sections 2.8
and 2.9. The immunoprecipitations indicate that the AP-3 complex, like
coventional adaptor complexes, consists of a a /g  like subunit ( d ), a b subunit, a m
subunit, and a s subunit.
Figure 4.3
Primary mouse fibroblasts fixed with -20°C methanol/acetone and labelled with an 
antibody against the d subunit of the AP-3 complex. The cells were processed as in 
Materials and Methods section 2.6. Scale bar 20m M.
65
dTR
d
/T
R
Fi
gu
re
 4
.4
N
R
K 
ce
lls
 w
er
e 
fe
d 
an
 a
n
ti-
tra
ns
fe
rri
n 
re
ce
pt
or
 a
n
tib
od
y 
(1/
10
0 
D
M
EM
)  f
or 
1 h
ou
r 
a
t 3
7°
C.
 T
he
 c
ell
s 
w
er
e 
fix
ed
 
a
n
d 
st
ai
ne
d 
w
ith
 a
n 
an
tib
o
dy
 a
ga
in
st 
th
e 
d
 
su
bu
ni
t o
f t
he
 A
P-
3 
co
m
pl
ex
 (c
ell
s w
ere
 p
ro
ce
ss
ed
 a
s 
in
 
M
at
er
ia
ls 
a
n
d 
M
et
ho
ds
 
se
ct
io
n 
2.
6).
 
Th
e 
m
e
rg
ed
 im
ag
e 
sh
ow
s l
im
ite
d 
co
lo
ca
lis
at
io
n.
 S
ca
le
 b
ar
 2
0m
M
dCD
63
d
/C
D6
3
Fi
gu
re
 4
.5
CO
S 
ce
lls
 w
er
e 
fix
ed
 a
nd
 s
ta
in
ed
 w
ith
 a
nt
ib
od
ie
s 
ag
ai
ns
t t
he
 d 
su
bu
ni
t o
f t
he
 A
P-
3 
co
m
pl
ex
 a
nd
 C
D6
3 
(ce
lls
 
w
e
re
 p
ro
ce
ss
e
d 
as
 in
 M
at
er
ia
ls 
a
n
d 
M
et
ho
ds
 s
ec
tio
n 
2.
6).
 
Th
e 
m
e
rg
ed
 im
ag
e 
sh
ow
s 
th
a
t t
he
 tw
o 
pa
tte
rn
s 
do
n
o
t c
ol
oc
al
is
e.
 S
ca
le
 b
ar
 2
0 m
M
.
dCl
at
hr
in
d
/C
la
th
rin
Fi
gu
re
 4
.6
Co
nf
oc
al
 m
ic
ro
gr
ap
hs
 o
f a
n
 N
R
K 
ce
ll 
la
be
lle
d 
fo
r d
 
a
n
d 
cl
at
hr
in.
 
N
R
K 
ce
lls
 w
er
e 
fix
ed
 a
nd
 la
be
lle
d 
wi
th
 a
n
ti-
d
 
a
n
d 
a
 a
n
tib
od
y 
ag
ai
ns
t t
he
 c
la
th
rin
 h
ea
vy
 c
ha
in
. C
ell
s 
w
er
e 
pr
oc
es
se
d 
as
 in
 M
at
er
ia
ls 
a
n
d 
M
et
ho
ds
 
se
ct
io
n 
2.
6.
 T
he
 
m
e
rg
ed
 im
a
ge
s 
sh
ow
 lim
ite
d 
o
ve
rla
p 
co
n
si
st
en
t w
ith
 th
e 
tw
o 
co
at
s 
be
in
g 
on
 s
im
ila
r m
e
m
br
an
es
 b
ut
 d
iff
er
en
t 
bu
dd
in
g 
pr
o
file
s.
 S
ca
le
 b
ar
 2
0m
M
 
Figure 4.7
Panel (a) shows rat liver homogenate (LH) and rat liver clathrin coated
vesicles (CCV) run on a 10% acrylamide gel stained with Coomasie
blue (        indicates the clathrin heavy chain, * indicates the adaptins).
There is approximately twice as much LH loaded per lane as CCV.
Liver homogenate was generated by homogenising fresh rat liver in
phosphate buffered saline (Materials and Methods section 2.7).
Panel (b) shows a Western blot from an equivalent gel as shown in
panel (a). The appropriate region of the blot was probed with either
anti-s 3A or s 1 antibodies. Western blotting was performed as in
Materials and Methods section 2.8. The Western blots indicate that the
AP-3 complex is notenriched inCCV.
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Figure 4.8
NRK cells were labelled for 3 hours with 1mCi 32P-orthophosphate. The cells
were detergent extracted and native immunoprecipitations with antibodies
against g , s 3A, b 3A and d  were performed (Materials and Methods section 2.9).
The samples were resolved on a 8.5% acrylamide gel and then stained with
Coomasie blue. The gel was dried and exposed to X-ray film overnight. The
immunoprecipitations suggest that the b 3A subunit is phosphorylated.
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Chapter 5
Insights into the function of the AP-3 complex
5.1 Introduction
Mutant Drosophilia
The first insights into the function of the AP-3 complex came from a study
carried out by Dr Margaret S. Robinson, who searched the non-redundant
EST database for AP-3 subunit homologues, and discovered that the human d
subunit is closely related to the protein product of the Drosophila garnet gene
(Simpson et al., 1997). The garnet (g) locus was first described in 1916 as a
fly eye colour mutant, and was cloned by P element tagging by Dr V. Llyod
(GenBank DMU31351). The protein encoded by the garnet gene and the
human d  subunit show a high degree of homology in their N-terminal domains,
with a stretch of ~100 amino acids where the two proteins are ~96% identical.
The high degree of homology suggests that garnet gene encodes the
Drosophila d  subunit. To analyse the mutant phenotype Dr M. S. Robinson
obtained wild type and garnet flies (two garnet alleles were examined, g3 and
g53d), sections were cut from their eyes and examined by bright field and
phase contrast microscopy. The sections revealed that the organisation of the
g3 and g53d fly eyes appeared normal compared to wild type eyes, although
there was a reduction in the pigmentation of the cells surrounding the
ommatidia, especially in g53d (the g53d mutation only effects eye pigmentation
while g3 effects both eye and body pigmentation). This result suggests that the
AP-3 complex might be playing a role in the biogenesis of pigment granules.
Pigment granules are thought to be modified lysosomes so it is possible that
the AP-3 complex also is involved in the biogenesis of lysosomes and/or
lysosome-related organelles (Simpson et al., 1997).
Mutant yeast
Cowles et al. (1997), performed a genetic screen for genes required for the
transport of alkaline phosphatase (ALP) to the vacuole (Cowles et al., 1997a).
The screen was designed to select for proteins that when over-expressed
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interfered with the transport of an ALP-based construct. Two genes when
over-expressed had this phenotype, ALP5 and ALP6. ALP5 encodes the gene
product Apl5p that is most homologous to the human d  subunit of the AP-3
complex, and ALP6 encodes the gene product Apl6p that is most homologous
to b 3A subunit of the AP-3 complex. To investigate the pathway further
Cowles et al. (1997) identified the other subunits of the yeast AP-3 complex
(Amp3p is most homologous to m 3A and Aps3p is most homologous to s 3)
and individually knocked them out and investigated their effects on ALP
sorting. As expected deletion of any of the subunits interfered with the correct
sorting of ALP to the vacuole. Like ALP the vacuolar t-SNARE Vam3p is also
missorted, suggesting that the yeast AP-3 complex is also required for its
transport. In AP-3 deleted cells both Vam3p and ALP accumulate in vesicles
and membranes which do not contain vacuolar markers.
The results from both the yeast and the Drosophila studies suggest that in
mammalian cells the AP-3 complex will probably be involved in the transport
of proteins to lysosomes and lysosome-related organelles (the equivalent
organelle of the yeast vacuole or the insect pigment granule).
Mutant mice
Dr Margaret S. Robinson was contacted independently by two groups led by
Dr Margit Burmeister and Dr Richard T. Swank who work on mouse models of
the human genetic disorder Hermansky-Pudlak syndrome (HPS). HPS is a
disorder characterised by hypopigmentation, prolonged bleeding times, colitis
(inflammation of the colon), decreased renal lysosomal enzymes in the urine
and fibrotic lung disease. The disease occurs in diverse populations world-
wide and is especially prevalent in selected regions, such as Puerto Rico.
Patients with the disorder have an increased mortality rate.
There are at least 15 mouse complementation groups (pale-ear, mocha,
pearl, pallid, light-ear, maroon, ruby-eyed, subtle-grey, cocoa, cappuccino,
reduced-pigment, muted, sandy , beige and ruby-eye-2J) that have
phenotypes similar to HPS, such as dilute coat and eye colouring, abnormal
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platelets, lysosomal abnormalities, failure to secret lysosomal enzymes in to
the urine and fibrotic lung disease. Out of the 15 mouse complementation
groups, only 2 of the genes have been identified and cloned LYST-1 and
HPS.  LYST-1, a gene of unknown function, is mutated in the mouse mutant
beige and human Chediak-Higashi syndrome. The HPS gene, also of
unknown function, is mutated in the mouse mutant pale-ear and in the
majority of HPS patients from Puerto Rico (Swank et al., 1998).
The reason for the two groups contacting Dr M. S. Robinson was that the b 3A
gene mapped very closely to the pearl  (pe) locus, the d  gene mapped very
closely to the mocha (mh) locus. In addition the garnet mutation gave
pigmentation defects very similar to mh and pe, making the b 3A and d  genes
very strong candidates for the genes mutated in the mh and pe mice.
5.2 Characterisation of the mh and pe mutations
Characterisation of the mh mutation
Dr Margit Burmeister's research group was involved in mapping the mouse
mutant mh. mh, like other HPS model mice, has reduced pigmentation,
decreased renal lysosomal enzymes in their urine, abnormal platelets,
lysosomal abnormalities. mocha, pallid and muted mice also have inner-ear
degeneration and neurological abnormalities. Figure 5.1 shows an example of
a wild type litter-mate next to a mh mouse.  The mh mouse is showing several
phenotypes associated with HPS, reduced pigmentation and inner ear defects
(note the pale coat, skin colour and balance problems).
mh was mapped to mouse chromosome 10 and an equivalent region on
human chromosome 19. The mh allele was mapped to within ~0.5cM of
several markers on chromosome 10 by several different mouse crosses. A
physical map of ~2000kb encompassing the region was constructed by pulse
field gel electrophoresis, and candidate genes identified by their ability to
hybridise to this region (mouse chromosome 10 ESTs, chromosome 10
genes, human chromosome 19 ESTs and genes were investigated). One of
74
the ESTs that mapped to this region encoded the d  subunit of the AP-3
complex. To investigate if the d  gene contained the mh mutation, genomic
digests followed by Southern blotting with probes against the d  subunit were
performed from wild type, mh and mh2J DNA (mh2J is another allele of mh).
The genomic digests and Southern blots indicated that there was a
rearrangement in both mh and mh2J DNA. The rearrangement in mh is caused
by a 12kB deletion from the 5' end of the d  gene (the nature of the mh2J will be
discussed later).
To investigate what effect the rearrangement had on the d  transcript, Northern
blots and RT-PCR were performed from wild type and mh brain tissue. The
Northern blots and reverse RT-PCR indicated that the d  message was still
present in mh tissue, except it was ~500bp shorter than the wild type
message. Sequencing of the RT-PCR product indicated that there was 496bp
deletion starting just shortly after the initiator ATG, that is predicted to cause
an in-frame stop codon after the deletion (Kantheti et al., 1998).
Characterisation of the pe mutation
Dr Richard Swank's group was involved in the mapping of the pe mutation.
The pe mouse like mh has many of the HPS associated phenotypes as
mentioned earlier. pe was mapped to mouse chromosome 13 and was within
~0.5cM of several markers. The high-resolution mapping allowed a physical
map of the region to be constructed from a series of yeast artificial
chromosomes (YACs) and bacterial artificial chromosomes (BACs). To
identify candidate genes for pe, several BACs mapping to the region were
subjected to exon trapping. One of the exons trapped encoded C-terminal
region of b 3A. To investigate if the b 3A gene contained the pe mutation,
genomic digests followed by Southern blots with probes against the b 3A
subunit were performed from wild type, pe and pe8J DNA (pe8J is another allele
of pe). The genomic digests and Southern blots indicated that there were
rearrangements in both pe and pe8J DNA (personal communication, Dr R. T
Swank). To investigate what effect the rearrangement had on the b 3A
message, RT-PCR and Northern blots were performed on wild type and pe
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tissue. The Northern blots revealed that the pe message was larger than
expected and was decreased in intensity compared to the wild type message.
Sequencing of the RT-PCR products revealed that the message contained a
tandem duplication of 793bp. This duplication is predicted to cause an in-
frame stop codon at the duplication site, and would cause 130 amino acid to
be truncated from b 3A (Feng et al., 1998).
These results, in conjunction with the mapping, indicate that the mh and pe
gene encodes the d  and b 3A subunits of the AP-3 complex, and
rearrangements in these genes probably cause the associated phenotypes.
To further investigate the mh and pe mutations, collaborations were initiated
between Dr M. S. Robinson, Dr M. Burmeister and Dr R. T. Swank's
laboratories. Wild type, mh and pe tissues were sent to Dr M. S. Robinson
laboratory by Dr M. Burmeister and Dr R. T. Swank. Wild type, mh and pe
mice were obtained from The Jackson Laboratory and breeding colonies
established in Cambridge. R. T. Swank also sent a pe immortal fibroblast cell
line to Dr M. S. Robinson laboratory. To further aid the analysis of the mh
mutation I generated an immortal fibroblast cell line from the mh mice
(Materials and Methods section 2.4).
Western blots from mh and pe
To characterise the effects of the mh and pe mutations on the AP-3 complex,
mh and pe samples were homogenised and boiled in sample buffer (Materials
and Methods section 2.7). The samples were resolved by SDS-PAGE and
then blotted overnight. The blots were probed with antibodies against the
subunits of the AP-3 complex.
Figure 5.2 shows a series of Western blots from mh brain tissue, control brain
tissue, mh  and control cells (melan-a cells), which were probed with
antibodies raised against various AP-3 subunits and an antibody against the g
subunit of the AP-1 complex as a control. The anti- d  antibody (raised against
the N-terminal region) gave no signal at any position on the mh brain and mh
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fibroblasts sample Western blots, suggesting the out-of-frame deletion in mh
causes a null. To confirm that no truncated d  was being made from another
initiator site, Western blots were probed with antibodies raised against the C-
terminal region of d (see Table 2.2 Antibodies) and no signal was detected
(data not shown). Interestingly, the other subunits of the AP-3 complex are
also greatly reduced or undetectable from mh sample Western blots. A
Northern blot for s 3A indicated that s 3A was still being synthesised
(performed by Dr M. Burmeister). These results indicate that the mh mutation
is a null, and that the d  subunit is essential for the stability of the other
subunits of the AP-3 complex (Kantheti et al., 1998). Interestingly the s 3
subunit appears to be more stable than the other subunits, as trace amounts
of s 3 can be detected in the mh samples.
Figure 5.3 shows a series of Western blots from control cells (melan-a), pe
fibroblasts, control brain tissue and pe brain tissue (see above for antibodies
used). The anti- b 3A antibody gave no detectable signal from pe fibroblasts.
The levels of the d  and s 3 subunits do not seem to be severely affected by the
absence of b 3A in pe fibroblasts, although m 3A has become undetectable. A
Northern blot for m 3A indicated that m 3A was still being synthesised
(performed by Dr R. T. Swank). The levels of b 3B and m 3 in brain tissue
appear to be unaffected by the pe mutation, suggesting that there is functional
AP-3 complex in pe brain tissue. These results indicate that pe allele causes a
severe reduction in the amount of b 3A in pe mice (possibly due to mRNA and
protein instability), and that b 3A is essential for the stability of the m  subunit in
the AP-3 complex  (Zhen et al., 1999).
The pearl mutation is not a null
Western blotting and native immunoprecipitation experiments from p e
fibroblast have proven to be uninformative in indicating whether pe is a true
null or whether a small amount of b 3A is still being expressed. To try and
resolve this problem spleens from control and pe mice were used for native
immunoprecipitations and Western blotting experiments (Materials and
Methods sections 2.8 and 2.9). pe and control spleens were
77
immunoprecipitated with antibodies raised against b 3A and g  as a control. The
samples were subjected to SDS-PAGE and then Western blotted, and
appropriate strips cut from the blots and probed with anti-d , b 3A, m 3A, s 3A
and g  as a control.
Figure 5.4 shows an example of such a series native immunoprecipitation and
Western blotting experiments from pe and control spleens (Materials and
Methods sections 2.8 and 2.9). The results indicate that b 3A is present in pe
tissue at very low levels and that the truncated b 3A is able to incorporate into
the AP-3 complex, as b 3A brings down d , m 3A and s 3A in the native
immunoprecipitation.
Immunoprecipitations from mh and pe fibroblasts
It has been previously shown, that there are strong interactions between the
b / m  subunits and s / a, g  subunits of the AP-1 and AP-2 complexes using the
yeast two-hybrid system (Page and Robinson, 1995). The data from the pe
and mh Western blotting experiments (Fig. 5.3 and 5.4) suggested that a s /d
sub-complex might be being formed in pe cells, as the d  and s 3 subunits
appeared to be more stable than expected (in mh all of the subunits are
severely reduced). To investigate this, native immunoprecipitation and
Western blotting experiments were performed from pe and mh cells, as
described in Materials and Methods sections 2.8 and 2.9.
Figure 5.5 show an example of a series of native immunoprecipitation and
Western blotting experiments from p e fibroblasts. pe fibroblast were
immunoprecipitated with antibodies against m 3, s 3, d  and an antibody against
g  as a control. The samples were subjected to SDS-PAGE and then Western
blotted, and appropriate strips cut from the blots and probed with the above
antibodies (Materials and Methods sections 2.8 and 2.9). The s 3 and d
immunoprecipitations indicate that a s/d  sub-complex is being formed in the
pe cells, as the s 3 immunoprecipitation brings down d,  and conversely the d
immunoprecipitation brings down s 3. The s 3 and d  immunoprecipitation also
brings down a non-stoichometric amount of m 3A. The m 3A is probably not
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directly interacting with d  and s 3 but with trace amounts of b 3A brought down
in the immunoprecipitation (the m 3 antibody is more sensitive at detecting itself
on a Western blot than the b 3A antibody, this would explain why m 3A can be
detected in the s 3 and d  immunoprecipitations, while b 3A can not).
To investigate if m 3A, b 3A, s 3 subunits are being expressed in mh fibroblast
and if b 3A and m 3A interact, native immunoprecipitations and Western blotting
experiments were performed as above.
Figure 5.6 show an example of a series native immunoprecipitation and
Western blotting experiments from mh fibroblasts. mh fibroblast were
immunoprecipitated with antibodies against d , m 3, b 3A, s 3  and an antibody
against g  as a control. The samples were subjected to SDS-PAGE and then
Western blotted, and appropriate strips cut from the blots and probed with the
above antibodies. The immunoprecipitations indicated that m 3A, b 3A and s 3
are all being synthesised in mh fibroblasts, and b 3A and m 3A interact with
each other as m 3A comes down in the b 3A immunoprecipitation. In contrast,
s 3 appears to not to be free.
The mh and pe immunoprecipitation results biochemically confirm the yeast
two hybrid studies previously performed by Page et al. (1995), and extend
them to the AP-3 complex (Page and Robinson, 1995).
Localisation of the AP-3 complex in mh and pe
To investigate the effect of the pe and mh mutations on the localisation of the
AP-3 complex, control (melan-a), mh and pe fibroblasts were fixed and
stained with anti- d  antibodies (Materials and Methods section 2.6) (Fig. 5.7).
The mh fibroblasts showed no staining for d, as would be expected, however
the pe cells showed diffuse staining for d , indicating that the d /s  sub-complex
described in Fig. 5.5 is unable to associate with membranes in pe cells. This
result indicates that the d /s  sub-complex is not functional.
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5.3 Characterisation of the mocha 2J (mh2J) mutation
mh2J is another allele of mh, which has an overall less severe phenotype than
mh  (less severe pigment dilution, clotting problems and balance problems)
except mh2Jhas more pronounced neurological abnormalities (hyperactivity
and handling-induced seizures). The mutation has not been mapped
completely, although it is known that mh2J allele, like mh, has a genomic
rearrangement (Kantheti et al., 1998). Analysis of mh 2 J Northern blots
revealed that there are two mRNAs for d  instead of one in wild type tissues.
The most abundant mRNA is much larger than wild type message and the
other is the same size as the normal message. Sequence analysis of RT-PCR
products, has revealed that the larger message contains a large insertion
which would lead to a in-frame stop codon in the hinge domain, at amino acid
858 of the d  subunit. Sequencing of the normal sized RT-PCR product has
revealed that it encodes the wild type d  protein. It is thought that the wild type
message is created by splicing-out the insertion from the mutant message (Dr
M. Burmeister, personal communication).
Immunoprecipitations from mh2J
To characterise the mh2J mutation further, native immunoprecipitations were
performed from control and mh2J liver, brain and spleen tissue, using
antibodies against d  and s 3 (Materials and Methods sections 2.8 and 2.9)
(Fig. 5.8).  The native immunoprecipitations indicate that in mh2J tissue, there
is both wild type and truncated d  subunit expressed, as anti- d
immunoprecipitations not only brings down wild type sized d  (~160kD) but
also a band at ~120kD. The truncated d  subunit is also able to incorporate into
the AP-3 complex, as s 3A immunoprecipitations brings down not only wild
type d  but also truncated d . In addition these results indicate that there is
relatively less wild type d  in brain tissue compared to the other tissues
examined.
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Localisation of the AP-3 complex in mh2J
To investigate the mh2J mutation further, wild type and mh2J primary fibroblasts
were generated from 2-3 day old decapitated mice, sent on ice from Dr M.
Burmeister. The primary fibroblasts were fixed and stained with anti- d  N and
C-terminal antibodies (Materials and Methods section 2.6) (Fig. 5.9). The anti-
N-terminal antibody recognises both wild type and truncated protein and the
C-terminal antibody only recognises wild type protein. The staining pattern
produced with the N-terminal anti- d  antibody was similar to wild type cells,
except the intensity of the staining was decreased. Very little staining was
observed with the C-terminal anti- d  antibody (very faint labelling was
observable in some cells, data not shown). This result indicates that there is
very little wild type d  in mh2J fibroblasts, and that the AP-3 complex containing
the truncated d  subunit is able to recruit on to membranes and might be
functional.
5.4 b 3B is able to incorporate into non-neuronal AP-3 complexes
pe  cells stably expressing b 3B were generated by transfecting pe cells with
b 3B pMEP DNA, and selecting with hygromycin as described as in Materials
and Methods section 2.4. Hygromycin resistant colonies were picked and
screened by immunofluorescence using an anti-b 3B antibody (Table 2.2
Antibodies). Figure 5.10 shows a series of fluorescence micrographs from
untransfected pe cells and pe cells stably expressing b 3B, fixed and stained
for anti- b 3B and d  antibodies (Materials and Methods section 2.6). The
fluorescence micrographs show that when b 3B is transfected into pe cells the
d  staining goes from being diffuse to punctate, suggesting that the b 3B is able
to incorporate into the non-neuronal AP-3 complex (containing m 3A) and then
associate with membranes. To confirm this result, native
immunoprecipitations were performed from untransfected and stably
expressing b 3B pe cells, with antibodies raised against d  and b 3B. The
samples were Western blotted and strips cut from the appropriate regions and
probed with anti- d , b 3B, m 3 and s 3 antibodies (Materials and Methods
sections 2.8 and 2.9) (Fig. 5.11). The native immunoprecipitations indicate
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that the b 3B subunit is able to incorporate into the non-neuronal AP-3
complex, as the b 3B and d  immunoprecipitations bring down d , b 3B, m 3 and s 3
from stably transfected pe cells.
5.5 LAMPI is missorted in mh fibroblasts
Distribution of LAMPI and LIMPII in mh and pe fibroblasts
While this work was under way, a paper from Dr B. Hoflack laboratory was
published, suggesting that the AP-3 complex might be involved in trafficking of
LAMPI and LIMPII (Le Borgne et al., 1998). Le Borgne et al. (1998) used
antisense oligonucleotides to decrease the levels of m 3A in tissue culture
cells. The anti-sense oligonucleotides decreased the levels of m 3A by ~50%.
The antisense did not grossly affect the steady state localisation of LAMPI
and LIMPII, but affected the amount of LAMPI and LIMPII trafficking via the
cell surface (detected by antibody uptake experiments). The treatment of cells
with antisense oligonucleotides had no effect on the processing of Cathepsin
D.
To investigate if the mh and pe mutations cause a similar missorting of LAMPI
and LIMPII, as the anti-sense studies, control (primary mouse fibroblasts), mh
and pe fibroblasts were fixed and stained anti-LAMPI and LIMPII antibodies
(see Table 2.2 Antibodies) (Fig. 5.12). The fluorescence micrographs indicate
that there is no gross missorting of LAMPI and LIMPII in pe and mh fibroblasts
compared to control primary fibroblasts.
Transient transfections in mh
From the steady state labelling of LAMPI and LIMPII in wild type, mh and pe
cells it became apparent that any differences in localisation of the markers
due to the mh and pe mutations would be subtle, therefor an antibody uptake
approach would be required.
It was decided that the best approach to reveal any differences in LAMPI and
LIMPII trafficking, would be to transiently transfect the mh fibroblasts with wild
82
type d  cDNA in pMEP, followed by antibody uptake experiments. The
transient transfections would allow the comparison of antibody uptake
between transfected and untransfected cells, so providing an in-built control.
Figure 5.13 shows and example of such an transfection and antibody uptake
experiment. The mh cells were transfected with d  in pMEP (Table 2.3
constructs) using Fugene overnight (Materials and Methods section 2.4). 48
hours after transfection the cells were allowed to endocytose Alexa 350
labelled wheat germ lectin as an endocytocis control and an antibody against
LAMP1 (Materials and Methods section 2.11). The cells were fixed and
stained with anti- d  antibodies (Materials and Methods section 2.6). The
fluorescence micrographs indicate several results.  Firstly, the anti- d  staining
indicates that cells transfected with d  cDNA are able to make AP-3 complex
that can recruit on to membranes. Secondly, the transfection process does
not inhibit endocytocis, as wheat germ lectin positive structures are present in
transfected cells. Thirdly, LAMPI traffics less via the cell surface in these cells
as less LAMPI internal staining is present in transfected cells. To confirm this
result, 30 micrographs from this experiment (35 transfected cells) were
examined. It was found that in the majority of transfected cells (>80% 30 out
of 35) the trafficking of LAMPI was less via the cell surface. In the five cases
where a reduction LAMPI trafficking via the cell surface was not observed, the
cells were either expressing very low or very high levels of the d  subunit. This
type of experiment was repeated several times and similar results were
obtained (data not shown). These results indicate that in mh cells expressing
the d  subunit, LAMPI traffics less via the cell surface than in mh cells lacking
functional AP-3 complex.
Unfortunately this type of experiment is not possible with the pe cells, as high
enough transfection efficiencies could not be obtained, even after trying
several different transfection reagents.
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5.6 Development of a quantitative assay for AP-3 function
The development of a quantitative missorting assay would not only allow the
more accurate determination of LAMPI missorting, it would also allow the
comparison of wild type and mutant constructs stably transfected into mh and
pe cells, so giving a better insight into AP-3 function.
The quantitative missorting assay is based on the same immunofluorescence
antibody uptake assay, as used in section 5.4, except mock and transfected
cells are grown on multi-well plates and 125I-protein A is used to detect the
endocytosed antibodies. The amount of antibody bound or endocytosed is
compared between the transfected and mock-transfected cells (as described
in Materials and Methods section 2.11). Figure 5.14 shows a flow diagram of
the protocol.
The development of this assay has been hindered, as making stables
expressing the d  subunit in mh or the b 3A subunit in pe cells has been more
difficult than expected, although pe cells stably expressing the neuronal
isoform b 3B have been established. To try and resolve these problems,
several new constructs have been generated by Rachel Rudge. These
constructs are now being tested.
Preliminary uptake experiments
To ascertain if the assay was feasible, several preliminary experiments were
performed on pe and p e cells stably expressing b 3B. To determine the
appropriate concentrations of antibodies and cells to use in the assay, a crude
titration experiment was performed (Fig. 5.15).  The concentrations of anti-
LAMPI (2.04 m g/ml) and anti-CD44 (2.92 m g/ml) (CD44 is not endocytosed)
antibodies were kept constant and the concentration of cells varied. The
titration experiment indicated, that the concentration of anti-CD44 antibody
became limiting before the concentration anti-LAMPI antibody, for the same
number of cells. This experiment indicates how important it is for the correct
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concentration of antibodies and cells to be used, if the assay is to be
meaningful.
Once the appropriate concentrations of anti-CD44 and anti-LAMPI antibodies
were determined, a preliminary quantitative LAMPI missorting assay was
performed on pe cells stably expressing b 3B (Materials and Methods section
2.11). The experiment was performed at both 37°C and 4°C (4°C inhibits
endocytocis)(Fig. 5.16). The anti-CD44 panel indicates that approximately the
same numbers of mock and stably transfected b 3B pe cells (pe*) were used in
each experiment. This experiment indicates that the pe cells expressing b 3B
have less LAMPI trafficking via the cell surface, as both the levels of cell
surface  (4°C) and internalised  (37°C) LAMPI were reduced compared to
mock transfected pe cells. However the amounts of LAMPI in rescued and
non-rescued cells need to be measured, as in some lysosomal storage
diseases the levels of LAMPI expression changes (Meikle et al., 1999).
It is worth noting that the quantitative pe b 3B rescue experiment does not
appear to be as striking (not as large as a difference between mock and
transfected cells) as the mh rescue experiment (Fig. 5.10). The differences in
the levels of rescue between the mh and pe experiments are probably due to
the mock transfected pe cells being heterogeneous in their uptake of LAMPI,
as observed in preliminary immunofluorescence experiments (data not
shown). This heterogeneity would make the difference between mock and
transfected cells smaller, however it can be not ruled out that the b 3B might
only be able to partially compensate for the absence of b 3A. To resolve this
problem clonal mock transfected cells and pe cells expressing b 3A are being
generated. This result suggests that b 3B is able to form functional AP-3
complex in non-neuronal cells, thus at least partially rescuing the pe mutant
phenotype.
Figure 5.1
Wild type mouse next to a mocha littermate. Note the reduced pigmentation and 
balance problems of the mocha mouse.
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Figure 5.2
The mh and control samples were homogenised, subjected to SDS-PAGE
and Western blotting (Materials and Methods sections 2.7 and 2.8). Blots
were probed with antibodies to various AP-3 subunits and with an antibody
against the g  subunit of the AP-1 complex as a loading control. In the mh
samples, absence of the d  subunit leads to severe reduction in the other
subunits of the AP-3 complex.
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Figure 5.3
The pe and control samples were homogenised, subjected to SDS-PAGE
and Western blotting (Materials and Methods sections 2.7 and 2.8). Blots
were probed with antibodies to various AP-3 subunits and with an antibody
against the g  subunit of the AP-1 complex as a loading control. In the pe
samples, absence of the b 3A subunit leads to severe reduction of the m 3
subunit.
gb 3A b 3A
+
d
b 3
m 3
s 3
g
pe
Figure 5.4
Native immunoprecipitations from pe spleen were performed using antibodies
raised against b 3A and the g  subunit of the AP-1 complex as a control (Materials
and Methods sections 2.8 and 2.9). The pe mutation is not null, as a small
amount of truncated b 3A is still detectable. The truncated b 3A can incorporate
into the AP-3 complex as the other AP-3 subunits are brought down in the anti-
b 3A immunoprecipitation.
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Figure 5.5
pe fibroblasts were immunoprecipitated with antibodies against d, b 3A, s 3 and an
antibody against g  as a control under native conditions. The m 3A (*)
immunoprecipitation was performed under denaturing conditions
(immunoprecipitation buffer was supplemented with 0.3%SDS) as the antibody
only works under these conditions. The samples were subjected to SDS-PAGE
and then Western blotted, and appropriate strips cut from the blots and probed
with the above antibodies (Materials and Methods sections 2.8 and 2.9). The
immunoprecipitations indicate that d  and s 3 are forming a subcomplex, despite
tha absence of b 3 and m 3.
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Figure 5.6
mh fibroblasts were immunoprecipitated with antibodies against d,  b 3A, s 3
and an antibody against g  as a control under native conditions. The m 3A (*)
immunoprecipitation was performed under denaturing conditions
(immunoprecipitation buffer was supplemented with 0.3%SDS) as the antibody
only works under these conditions. The samples were subjected to SDS-
PAGE and then Western blotted, and appropriate strips cut from the blots and
probed with the above antibodies (Materials and Methods sections 2.8 and
2.9). The immunoprecipitations indicate that m 3A, b 3A and s 3A are all being
synthesised in mh fibroblasts, and b 3A and m 3A interact with each other, but
not with s 3.
wt mh pe
Figure 5.7
Control (melan-a), mh and pe cells were fixed and stained with an anti-d  antibody (Materials and Methods
section 2.6). There is no staining for the d  subunit in mh  cells, however pe  cells show diffuse staining which is
significantly above background staining. Scale bar 20m M.
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Figure 5.8
Native immunoprecipitations were performed from control (+) and mh2J (-) liver,
brain and spleen tissue using anti- d  and s 3 antibodies (Materials and Methods
sections 2.8 and 2.9). Both the wild type and truncated d  are expressed in mh2J
tissue, and the truncated protein is also able to incorporate into the AP-3
complex.
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Figure 5.9
Primary mouse mh2J and control fibroblasts were fixed and stained with N and C-
terminal anti-d  antibodies (Materials and Methods section 2.6). The staining pattern
produced with the N-terminal anti-d  antibody in mh2J was similar to wild type
fibroblasts, except the intensity of the staining was decreased. Very little staining
was observed in mh2J  fibroblasts with the C-terminal anti-d  antibody. This result
indicates that there is very little wild type d  in mh2J fibroblasts and that the AP-3
complex containing the truncated d  is able to bind to membranes.
93
pe*
b 3B
 pe
d
Figure 5.10
pe and pe* stables expressing b 3B were fixed and stained with antibodies
against b 3B and d  (Materials and Methods section 2.6). Micrographs show
that b 3B is able to incorporate into the non-neuronal AP-3 complex and the
complex is able to recruit on to membranes. Scale bar 20m M.
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Figure 5.11
Native immunoprecipitations using antibodies against d  and b 3B were performed
from untansfected pe and pe * cells stably expressing b 3B. The samples were
Western blotted and strips cut from the appropriate regions and probed with anti- d ,
b 3B, m 3 and s 3 antibodies (as described in Materials and Methods section 2.8 and
2.9). The native immunoprecipitations indicate that b 3B is able to incorporate into
the non-neuronal AP-3 complex.
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Figure 5.12
Wild type (mouse primary fibroblasts), mh and pe fibroblasts were fixed with -20°
methanol for 5 minutes and stained with anti-LAMPI and LIMPII antibodies (cells were
processed as in Materials and Method section 2.6). Staining patterns do not appear to be
grossly different between wild type, mh and pe cells. Scale bar 20m M.
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Figure 5.13
mh fibroblasts were transiently transfected overnight with d  in pMEP ( Materials and Methods section 2.4). 48 hours
after transfection the cells were fed Alexa labelled wheat germ lectin, as a control, and anti-LAMPI antibodies
(Materials and Methods section 2.11). The cells were fixed and stained with anti- d  antibodies to reveal transfected
cells (Materials and Methods section 2.6). These micrographs indicate, that mh cells expressing the d  subunit traffic
LAMPI less via the cell surface and the endocytocis of wheat germ lectin is not affected by this process. Scale bar
20m M.
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Cells were fed anti-LAMPI or CD44
antibodies for 6 hours. 
Cells were washed and fixed.
Cells were labelled with an anti-rat/rabbit 
antibody.
Cells were washed.
Cells were incubated with 
125I Protein A for 30 minutes.
Cells were extracted with NaOH and 
 the bound counts measured on a 
 g counter
Cells were passaged onto 24 well 
dishes and grown overnight.
Cells were washed.
Figure 5.14
Flow diagram of the quantitative mis-sorting assay (Materials and Methods
section 2.11).
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Figure 5.15
To determine the appropriate concentrations of cells and antibodies to use in the
mis-sorting assay, a crude titration experiment was performed in duplicate on pe
cells. pe cells were plated onto multi-well dishes at varying concentrations and
then fed anti-LAMPI (2.04m g/ml) and anti-CD44 (2.92m g/ml) antibodies for 6
hours, and then processed as described in Materials and Methods section 2.11.
The experiment indicates that CD44 antibody has become limiting, between
3.5x1004 and 7x1004 cells, and that the anti-LAMPI antibody has becoming
limiting between 7x1004 and 1.4x1005 cells.
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A preliminary antibody uptake experiment was performed on b 3B transfected pe (pe*) and mock transfected
pe cells as described in Materials and Methods section 2.11. The cells were either given control anti-CD44
antibody (anti-CD44 is not endocytosed) or an anti-LAMPI antibody at 4°C or 37°C. This  experiment
indicates that pe cells transfected with b 3B have less LAMPI trafficking via the cells surface, as the amount
of antibody bound in pe cells expressing b 3B is reduced compared to the pe fibroblasts at 37°C and °4C.
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Chapter 6
Discussion
This thesis has focused on the cloning and characterisation of the AP-3
complex. The characterisation of the complex has been greatly facilitated by
the discovery of Drosophilia and mice with mutations in several of the AP-3
subunits. These mutations have allowed experiments to be devised and
performed in mammalian cells that had previously only been possible in
genetically pliable model systems, such as yeast.
6.1 Composition and subunit interactions of the AP-3 complex
The cloning and immunoprecipitation studies indicate the AP-3 complex, like
conventional adaptor complexes, consists of a a /g  subunit ( d ). a b  subunit, a m
subunit and a s  subunit. The AP-3 complex is complicated by the fact that
there are two b  isoforms b 3A/ b 3B, two m  isoforms m 3A/ m 3B and two s  isoforms
s 3A/ s 3B. d , b 3A, m 3A, s 3A and s 3B are all expressed ubiquitously, although
s 3A and s 3B are expressed at different levels in different tissues (Pevsner et
al., 1994) (Simpson et al., 1996) (Simpson et al., 1997) (Dell'Angelica et al.,
1997a) (Dell'Angelica et al., 1997b). b 3B and m 3B are only expressed in
neuronal tissue (Newman et al., 1995) (Pevsner et al., 1994).  The complexity
of the AP-3 complex compared to conventional adaptor complexes, raises
several interesting questions. Are there neuronal isoforms of the d  and s
subunits, can the neuronal and non-neuronal subunits interact "mix and
match" and why are there neuronal specific isoforms of b  and m  ?
Characterisation of the mh and pe mice has given insights into several of
these questions.
Are there neuronal isoforms of the d  and s  subunits?
Searching the EST database with d  and s  subunits has not led to the
identification of any neuronal isoforms, although their existence can not be
ruled out. However it seems very unlikely that there is a neuronal isoform of
the d  subunit, as mh mice have neuronal abnormalities, in contrast to pe mice
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which do not have neuronal abnormalities, probably as the neuronal isoform
of b 3A, b 3B, is able to compensate for the absence of b 3A.
Subunit interactions
The characterisation of mh and pe fibroblasts has given several insights into
AP-3 subunit interactions. Western blotting and immunuoprecipitation studies
from mh and pe fibroblasts have biochemically confirmed yeast two hybrid
studies indicating that the b  and m,  and a /g  and s  subunits can interact (Page,
1996), as b 3A and m 3A, and d  and s 3A immunoprecipitate as heterodimers.
These studies have also indicated that the d  subunit is essential for the
stability of the whole complex as in its absence the other AP-3 subunits are
degraded. The b  subunit is also essential for the stability of the m  subunit as
when the b  subunit is absent the m  subunit becomes degraded.  The most
definitive way to increase our understanding of adaptor subunit interactions is
to resolve the adaptor complex's structure at atomic resolution. A
collaboration has been established with Dr David Owen to determine the
structure of the adaptor subunits.
Can the neuronal and non-neuronal subunits interact "mix and match"?
Transfection studies using pe fibroblasts has given an insight into whether the
neuronal and non-neuronal subunits can interact i.e. can b 3A interact with
m 3B and b 3B interact with m 3A. Immunoprecipitation studies from pe cells
transfected with b 3B indicated that b 3B is able to interact with m 3A and form
potentially functional complexes. Yeast two hybrid studies by Winnie Lui, a
PhD student in Dr M. S. Robinson's laboratory, have also indicated that b 3B is
able to interact with m 3A and that b 3A is able to interact with m 3B (personal
communication). These results suggest that the neuronal and ubiquitously
expressed subunits are promiscuous as b 3B (or b 3A) can interact with m 3A or
m 3B. However these experiments could be misleading as only one subunit out
of each pair of isoforms is present in each experiment, so subtle differences in
affinity would not be detected, thus it is still possible that there could be two
separate AP-3 complexes in neuronal tissue i.e. one containing b 3B/ m 3B and
the other b 3A/ m 3A. It is also not clear whether the same cell can co-express
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both m 3A and m 3B. One way this question can be resolved, is if m 3A and m 3B
specific antibodies can be generated.
6.2 Phosphorylation of the AP-3 complex
Immunoprecipitation studies indicated that the b 3A subunit is the major target
for phosphorylation in the ubiquitously expressed AP-3 complex. Support for
this result has come from a study performed by the laboratory of Dr J. S.
Bonifacino, that indicates that the b 3A subunit is phosphorylated, and that the
phosphorylation is restricted to serine residues (Dell'Angelica et al., 1997b).
The sequence analysis of b 3A and b 3B indicates that there are many
consensus casein kinase phosphorylation sites in the hinge domain.
Interestingly, several of these sites are conserved between the mammalian
and yeast b 3 subunits and a genetic interaction has been detected between
yeast casein kinase 1 and the AP-3 complex, suggesting that b 3A
phoshporylation might important for the function of the AP-3 complex
(Dell'Angelica et al., 1997b) (Panek et al., 1997). The precise role of b 3A and
b 3B phosphorylation in AP-3 function has still to be resolved. A study by the
laboratory of Dr R. Kelly has suggested that the phosphorylation of the b 3
subunit might affect the regulation of the AP-3 complex's ability to be recruited
onto membranes (personal communication, Dr V. Faúndez).
The b  subunits of the AP-1 and AP-2 complexes are also phosphorylated in
vivo but it is not clear what role phosporylation plays in AP-1 and AP-2
function (Wilde and Brodsky, 1996). A study by Wilde et al. (1996) indicated
that the phosporylation of the b 2 subunit inhibited the ability of the AP-2
complex to bind to clathrin in vitro, however their study did not conclusively
indicate if the phosporylation of b 2 modulates clathrin adaptor interactions in
vivo.
A possible way to precisely determine if the phosphorylation of the b 3 subunit
is essential for AP-3 function would be to transfect pe cells with b 3A or b 3B
104
constructs that no longer contained consensus phosphorylation sites in their
hinge domains, and then assay for function of the AP-3 complex.
6.3 Does the AP-3 complex interact with a structural scaffold?
As the AP-3 complex is related to AP-1 and AP-2, it was important to
determine if AP-3 complex interacts with clathrin. Previous studies by the
laboratory had shown that the neuronal AP-3 subunits were not localised or
enriched in clathrin-coated vesicles (Simpson et al., 1996). To investigate if
this was also true for the ubiquitously expressed AP-3 subunits, Western
blotting and immunofluorescence studies were performed on clathrin-coated
vesicles and tissue culture cells from non-neuronal sources. The studies
indicated that the AP-3 not was enriched or localised to clathrin-coated
vesicles (Simpson et al., 1997). These results remain controversial as two
studies performed by the laboratory of Dr J. S. Bonifacino added support but
also contradicted our findings (Dell'Angelica et al., 1998; Dell'Angelica et al.,
1997b).  In the first study by Dell'Angelica et al. (1997) concluded that the AP-
3 complex was not enriched in clathrin-coated vesicles based on Western
blotting experiments. In the later study by Dell'Angelica et al. (1998) the group
used GST- b 3A based constructs to carry out in vitro  "fishing" experiments
from cytosol. The b 3A based constructs fished out the clathrin heavy chain
from cytosol. They mapped the binding domains of b 3A and clathrin, to amino
acids 817 to 825 of the C-terminal "ear" domain of b 3A, and the N-terminal
portion of clathrin. The group also used an anti- b 3A antibody to carry out
immunofluorescence and immunoelectron microscopy studies. Their studies
revealed that ~65% of anti-b 3A positive structures were also positive for anti-
clathrin staining. The Dell'Angelica et al. (1998) results are unexpected and
contradictory to the previous findings. There could be several reasons why
their findings are contradictory. The ability of b 3A to bind to clathrin in vitro
may not reflect an interaction that occurs in vivo. Indeed several papers have
been published indicating strong in vitro interactions between adaptors and
other proteins (IRS1 and synaptotagmin), which have proven difficult to
substantiate in vivo (Zhang et al., 1994) (VanRenterghem et al., 1998). The
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colocalisation of b 3A with clathrin is very surprising and it could be explained if
the b 3A antibody is cross-reacting with b 1 or b 2. This is possible as the region
Dell'Angelica et al. (1998) used to raise the antibody against has many
domains that are highly conserved between the b 1, b 2 and b 3.
To try and resolve if b 3A interacts with clathrin in vivo, several experiments
have been undertaken in the Robinson laboratory. The b 3A subunit has been
FLAG tagged to allow the localistaion of the AP-3 complex in pe cells. b 3A
constructs missing the proposed clathrin binding domain (Dell'Angelica et al.,
1998) and a construct containing the b 2 clathrin binding domain (Shih et al.,
1995) will be generated and transfected into pe cells.  These constructs will
help determine if the proposed clathrin-binding domain in b 3A is essential for
AP-3 function. The role of clathrin in AP-3 function will also be investigated by
perturbing clathrin's ability to bind to adaptors, this will be achieved by
transfecting cells with a clathrin hub construct that acts as a dominant
negative (Liu et al., 1998). Together, these studies should indicate whether
AP-3 is able to interact with clathrin in vivo.
Alternative scaffold proteins
If the findings from our laboratory are correct, the AP-3 complex does not use
clathrin as a structural scaffold. Are there any other candidate molecules
which might act like a scaffold?
TheVPS41 gene encodes a protein that could be a potential scaffold for the
AP-3 complex. The VPS41 gene encodes a hydrophilic protein of 992 amino
acids. Analysis of the sequence revealed that the protein contains one clathrin
heavy chain repeat at amino acid 753-853 (zigzag motif) (Radisky et al., 1997;
Ybe et al., 1999). Mutations in VPS41 cause missorting of alkaline
phosphatase, similar to mutations in AP-3 subunits (Cowles et al., 1997b;
Radisky et al., 1997).  Mutations in the Drosophila VPS41 gene, called light,
also cause a phenotype similar to mutations in garnet  (Drosophilia AP-3 d )
and the two genes have been shown to genetically interact (Lloyd et al.,
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1998). Experiments performed in the laboratory of Dr S. Emr have sown that
yeast VPS41 is able to bind to the d  hinge/ear in vitro (Rehling et al., 1999).
To characteriseVPS41 in mammalian cells, antibodies have been raised
against a GST fusion protein encoding the C-terminal portion of VPS41. The
antibodies label a band of the appropriate sise on Western blots (data not
shown) and now can be used to determine in mammalian VPS41 binds to d
hinge/ear, and whether it is missing in any of the mouse mutants.
Another potential source of scaffold molecules for the AP-3 complex might
come from the further mapping and identification of the genes that cause
mouse (at least 11 genes unidentified) and Drosohilia  (8 genes unidentified)
pigmentation mutants, similar to garnet, mocha and pearl.
6.4 Localisation of the AP-3 complex
This study has confirmed and extended the previous study performed by
Simpson et al. (1996) The ubiquitously expressed AP-3 complex is associated
with both perinuclear and more peripheral membranes (Simpson et al., 1996)
(Simpson et al., 1997). The nature of the more peripheral membranes
remains elusive as there is only very limited colocalisation with early and late
endosomal markers. The lack of colocalisation of AP-3 with endosomal
markers and the predominance of AP-3 labeling on the trans Golgi network,
might suggest that the peripheral labeling is more likely to be associated with
a biosynthetic compartment. Another indication that the peripheral AP-3
labeling is associated with a biosynthetic compartment comes from a
preliminary study performed by Alex C. Theos in Dr M. S. Robinson's
laboratory. COS cells were transiently transfected with ZnT-3-GFP (Palmiter
et al., 1996), fixed and then stained with either anti- d  or anti-CD63 antibodies
(this neuronal specific zinc transporter is mislocalised in mh mice, see
Discussion section 6.4). The ZnT-3-GFP construct labeled both perinuclear
and more peripheral structures. The smaller peripheral structures labeled with
ZnT-3-GFP partially colocalised with AP-3 staining, and the larger structures
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with anti-CD63 staining. This preliminary experiment suggests that the AP-3
complex is associated with a compartment that is accessible from the
biosynthetic pathway and that ZnT-3 is the first molecule to show significant
levels of colocalisation with the AP-3 complex (personal communication, Alex
C. Theos).  Although ZnT-3 can be colocalised with AP-3 it has not been
possible to colocalise AP-3 with LAMPI, another potential cargo molecule.
There could be several reasons why there is partial colocalisation with ZnT-3
and AP-3, and not LAMPI. Firstly, the expression levels of ZnT3-GFP are
much higher than endogenous LAMPI, secondly ZnT3 is normally expressed
in neuronal cells so might not be efficiently sorted in non-neuronal cells (no
m 3B and b 3B) and thirdly ZnT-3 shows the most striking missorting defect out
of any of the potential AP-3 cargo molecules investigated, so might be more
dependent on AP-3 sorting. A possible way to trap LAMPI in an AP-3 positive
compartment, is to transiently transfect GFP tagged LAMPI into cells and
investigate if it partially colocalises with AP-3 staining.
6.4 Function of the AP-3 complex
Insights into the function of the AP-3 complex have come from the analysis of
three genetic models systems flies, yeast and mice. Mutations in the AP-3
complex in all three systems lead to similar mutant phenotypes in lysosome
related organelles. The similarity of the mutant phenotypes would suggest that
the AP-3 complex has a similar function in all three organisms.
Analysis of the garnet allele
The first insight into the AP-3 complexes function came from the analysis of
several Drosophilia garnet alleles (g3 and g53d). The garnet gene encodes the
d  subunit of the fly AP-3 complex (Simpson et al., 1997). Mutations in the
garnet gene affect both body and eye pigmentation. Analysis of garnet fly
eyes revealed that the overall organisation of the mutant eyes was normal
compared to wild type eyes, although there was a reduction in the
pigmentation of pigment granules surrounding the ommatidia (Simpson et al.,
1997). A study by Ooi et al. (1997) confirmed and extended the study by
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Simpson et al. (1997) by further characterising g3 and another mutant allele,
g50e, of garnet. A Nothern blot from g3, g50e and wild type flies, revealed that
the g3 mutation causes a truncation and g50e causes a severe reduction in the
d  mRNA. Dr J. S. Bonifacino's laboratory has also characterised several of the
other fly eye pigmentation mutants that genetically interact with garnet.
Interestingly 3 of these complementation groups (orange, carmen and ruby)
encode the other subunits of the AP-3 complex (personal communication, Dr
J. S. Bonifacino). These results indicate that the AP-3 complex is playing a
role in pigment granule biogenesis and/or in the trafficking of cargo to pigment
granules. It is thought that pigment granules are related to lysosomes so this
suggests that the AP-3 complex is also involved in the trafficking of lysosomal
proteins. This hypothesis is supported as there is another fly eye pigment
granule mutant, deep-orange, which is homologous toVPS18 (Shestopal et
al., 1997), and has been shown to be involved in the sorting of proteins to the
vacuole (in yeast)  (Robinson et al., 1991).
Analysis of yeast lacking AP-3 subunits
Cowles et al. (1997) identified that the AP-3 complex in yeast is essential for
the correct sorting of alkaline phosphatase and the vacuolar t-SNARE Vam3p
to the vacuole (Cowles et al., 1997b). This result was also confirmed by a
similar study performed by Stepp et al. (1997). The only other mutant
identified as being essential for the correct sorting of alkaline phosphatase
was VPS41.  Interestingly deletion of the clathrin heavy chain yeast does not
effect the sorting of alkaline phosphatase or Vam3p, indicating that AP-3 and
clathrin do not interact (Huang et al., 1999; Panek et al., 1997).
 Analysis of mutant mice (mh, pe and mh2J)
Mapping and Western blotting experiments in collaboration with Dr R.T Swank
and Dr M. Burmeister have revealed that the pearl phenotype is caused by a
mutation in b 3A, and the mocha phenotype is caused by a mutation in the d
subunit of the AP-3 complex (Feng et al., 1998; Kantheti et al., 1998; Zhen et
al., 1999). The mocha mutation is a null, as the mocha rearrangement leads
to an in-frame stop codon just after the start codon. Western blotting
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experiments from mh tissues and fibroblasts indicated that in the absence of
the d  subunit the other subunits of the AP-3 complex become destabilised.
Western blotting experiments from pe tissues and fibroblasts revealed that the
pe mutation leads to a severe reduction in the amount of detectable b 3A,
probably due to combined mRNA and protein instability (b 3A was only
detectable after enrichment by immunoprecipitation). In the absence of b 3A
the m 3 subunit becomes unstable, however the d  and s 3 subunits are still
detectable. The d /s  sub-complex formed in pe cells is unable to associate with
membranes indicating that the sub-complex is not functional.
Antibody uptake studies have indicated that LAMPI is trafficked more via the
cell surface in mh and pe fibroblasts compared to rescued cells, expressing
b 3B and d . To further characterise the sorting of LAMPI in mh and pe cells,
stable cell line expressing b 3A in pe and d  in mh will have to be generated. It
has proved very difficult to generate stables expressing full-length d . It
appears that unregulated expression of the wild type d  subunit is to toxic to
mh cells. To try and overcome this problem the d  subunit has been moved into
an inducible expression vector that is tetracycline responsive (Zeng et al.,
1998).
These results confirm the study performed by Le Borgne et al. (1998) which
stated that perturbations in AP-3 complex function cause LAMPI and LIMPII to
be trafficked more via the cell surface (Le Borgne et al., 1998). Interestingly, a
study by Dell'Angelica et al.  (1999) has identified a human patient with HPS
that has mutations in the b 3A subunit of the AP-3 complex.  As in mh and pe
fibroblasts, the trafficking of LAMPI is perturbed in the mutant human
fibroblasts. The Dell'Angelica et al. (1999) study has also identified that CD63,
another late endocytic marker, is also trafficked more via the cell surface in
these fibroblasts. The trafficking of CD63 has also been investigated in mh
and pe cells by Dr Brian A. Rous in the laboratory of Dr P. Luzio. mh and pe
cells were transfected with wild type and mutant CD63 constructs and the
localisation of these constructs observed. Interestingly, the localisation of wild
type CD63 was not grossly affected in mh and pe cells although a mutant
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CD63 construct, which bound poorly to m 2 in the yeast two hybrid system, was
found to be mainly on the cell surface and not in lysosomes (wild type tail
sequence GYEVM and mutant GYEVI). This construct in wild type mouse
fibroblasts or pe cells transfected with b 3B was mainly found in lysosomes
and not on the cell surface (personal communication, Dr B. A Rous).
These results support the hypothesis that AP-3 is involved in the sorting of
lysosomal transmembrane proteins to the lysosome. Perturbations in AP-3
function cause lysosomal proteins to be missorted to the cell surface, where
they are re-internalised by the AP-2 complex and then delivered to
lysosomes. However these results are indirect, and do not indicate whether
the AP-3 complex is involved in the direct binding and trafficking of LAMPI,
LIMPII and CD63, or another factor required for their correct sorting. It is
plausible that the unidentified factor could be a molecule such as a SNARE
since mistargeting of the SNARE in AP-3 deficient cells could then lead to
vesicles being targeted to the wrong compartment. Data to support this idea
already exists as the vacuolar t-SNARE Vam3p is mislocalised in AP-3
deficient yeast (Cowles et al., 1997a). To investigate this possibility,
antibodies against several SNAREs have been obtained from Dr R. H.
Scheller.
Does the AP-1 complex have any role in the sorting of LAMPI and LIMPII ?
The data from several studies indicate that lysosomal transmembrane
proteins (LAMPI and LIMPII) in the absence of functional AP-3 complex are
trafficked via the cell surface, and might suggest that LAMPI and LIMPII are
not sorted directly by the AP-1 complex (Dell'Angelica et al., 1999b; Le
Borgne et al., 1998). It has been postulated that the AP-1 complex is involved
in the sorting of lysosomal enzymes and transmembrane proteins (LAMPI and
LIMPII) to the lysosome via an endosomal intermediate. Many studies have
been performed that implicate the AP-1 complex in the trafficking of the M6P
receptor and its cargo to the endosomal system, reviewed by Le Borgne et al.
(1998), however there have been very few studies actually indicating that AP-
1 complex is involved in the trafficking of LAMPI and LIMPII to the lysosome.
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The main evidence suggesting that the AP-1 complex is able to traffic
lysosomal transmembrane proteins comes from in vitro binding studies
(Honing et al., 1996) (Honing et al., 1998). The Honing et al. (1998) study
used plasmon surface resonance to investigate adaptor binding to lysosomal
tail motifs (dileucine and tyrosine based). The binding experiments indicated
that AP-1 was able to bind to LAMPI and AP-3 was not. These results do not
reflect the in vivo analysis of LAMPI trafficking in cells defective in AP-3
function. It is possible that the in vitro binding studies were misleading, as
components normally present in the cell, which might provide specificity or
increase the affinity, would not be present in the in vitro experiments. Another
indication that AP-1 complex is not involved in the trafficking of LAMPI and
LIMPII is that the m 1 "knock out" mice show defects in mannose6-phosphate
receptor trafficking, and not in LAMPI and LIMPII trafficking (Dr Peter Schu,
personal communication). These results would suggest that there is little
strong evidence for the role of AP-1 in the trafficking of LAMPI and LIMPII to
lysosomes.
Is the "ear" domain of d  required for AP-3 function?
Immunoprecipitation and mapping experiments in collaboration with Dr M.
Burmeister have revealed that the mocha2J allele is caused by a genomic
insertion (possibly a transposable element). The insertion causes the d  mRNA
to contain a stop codon just after the codon for amino acid 858. The truncation
causes most of the C-terminal portion to be missing from the d  subunit ("hinge
and ear" domains). In all tissues examined so far, the insertion can be excised
by splicing. The removal of the insertion from the mRNA leads to both wild
type and truncated protein being expressed in the same tissues, although
brain tissue contains lower levels of wild type d  compared to other tissues
examined. As both wild type and truncated protein are expressed in mh2J cells,
examination of the truncation's effect on LAMPI trafficking would be difficult to
interpret. To simplify the system Rachel Rudge, a PhD student in Dr M. S.
Robinson's laboratory, has taken mh fibroblasts and stably transfected them
with a construct encoding the truncated cDNA. Surprisingly, the truncated
protein is able to reduce the amount of LAMPI trafficking via the cell surface
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(personal communication, Rachel Rudge). To determine if the truncated d
construct is fully functional, a stable cell line expressing the wild type d  subunit
is required. However the rescue by truncated d  was unexpected as the ear
domain of a -adaptin has been shown to be involved in the binding of a series
of proteins which are thought to be essential for AP-2 complex function
(Eps15, epsin and amphiphysin) (Traub et al., 1999). The g -adaptin ear
domain also has at least one binding partner (g -synergin) but it is not clear if it
is required for AP-1 function (Page et al., 1999). This result might be
indicating that adaptor complexes can function without interacting with these
other molecules and these other molecules may only play a role in the
modulation of adaptor complex function. Another interpretation of the result is
that the d  ear domain is not involved in the binding of other proteins, but this
seems unlikely as "fishing" experiments with the yeast d  hinge/ear have
isolated VPS41 as a binding partner (Rehling et al., 1999). A third possibility is
that the interacting proteins may be capable of binding to other sites in the
coat. This is supported by the observation that two of the a  ear binding
partners, amphiphysin and epsin can also bind to clathrin (McMahon et al.,
1997) (Wendland et al., 1999).
Why does the AP-3 complex have a neuronal specific b  and m  subunit?
The precise function of the AP-3 complex in neuronal cells has still to be firmly
established.  Several studies have given insights into the possible function of
the AP-3 complex in neurons. The AP-3 complex is localised to a perinuclear
compartment in the cell body, and also more peripheral staining in the
neurites of primary cultured neurons (anti- b 3B antibody) (Simpson et al.,
1996). The AP-3 complex has been shown to play a role in the generation of
synaptic vesicles in vitro, from PC12 enriched endosomes (Faundez et al.,
1998). Budding in the assay can be completely reconstituted by the addition
of purified ARF-1, AP-3 and endosomal membranes. Interestingly, the
budding assay only works if AP-3 has been purified from brain tissue and not
from a non-neuronal source (personal communication, Dr Victor Faúndez).
This data would suggest that the budding assay is dependent on the AP-3
complex containing the neuronal isoforms of b 3B or m 3B. The nature of the
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assay (endosomal membranes) and the dependence on neuronally purified
AP-3 complex would suggest that the AP-3 complex containing b 3B or m 3B
has a different function from the non-neuronal AP-3 complex.  The Faúndez et
al. data, taken in conjunction with the pe rescue experiments, might suggest
that b 3B and b 3A can perform non-neuronal tasks and that only b 3B is able to
perform neuronal tasks.
Interestingly, the budding assay is clathrin independent and the addition of
b 3A-GST fusion proteins, that bind clathrin in vitro (Dell'Angelica et al., 1998),
do not inhibit this assay but inhibit an assay for the generation of synaptic
vesicles from PC12 plasma membranes (AP-2 dependent) (Shi et al., 1998).
These results suggest that the AP-3 complex functions independently from
clathrin and supports claims made in this thesis (see section 4.5)
Can loss of functional AP-3 complex be correlated to the pleiotrophic
phenotypes observed in the mutant mice?
There are a very large numbers of phenotypes associated with the mh, mh2J
and p e mice. These include hypopigmentation, prolonged bleeding,
decreased secretion of lysosomal enzymes in the urine, colits, fibrotic lung
disease and the mh andmh 2J mice, specific neurological abnormalities
(hyperactivity and handling induced seizures). Can all of these phenotypes be
directly related to the missorting of proteins in the absence of functional AP-3
complex? In several of the mutant phenotypes, there is enough known about
the normal and diseased states to make a educated guess at the molecules
that might be mis-sorted in the AP-3 deficient mice. Two of these HPS
associated phenotypes are being investigated, the m h  and p e
hypopigmentation defects and the mh specific neurological abnormalities.
Neurological defects in mh mice
To try and determine why the loss of functional AP-3 complex causes
neurological abnormalities in mh mice, brain sections were prepared from mh
and control mice, and the morphology and vesicular zinc staining analysed in
the sections (Kantheti et al., 1998). Interestingly, the zinc staining was
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undetectable in the mossy fibers of the mh sections compared to control mice
sections. The gross morphology of the mh mossy fibers appeared normal
compared to control mice, with similar numbers of clear core vesicles present.
The absence of vesicular zinc staining in the mh sections suggested that a
zinc transporter might be getting missorted. A candidate molecule is the
neuronal zinc transporter ZnT-3. ZnT-3 is a multi-spanning transmembrane
protein that contains both a conserved dileucine and a tyrosine type motif
near its C-terminal (Palmiter et al., 1996). The mh sections were stained for
the ZnT-3, using a rabbit polyclonal antibody. In the control sections, ZnT-3
staining was present in synaptic vesicles of the mossy fibers but in the mh
sections the staining was absent. Interestingly, is some mh neurons a
perinuclear reticular staining pattern was present in the cell bodies. These
results suggest that the ZnT-3 zinc transporter is mislocalised in the m h
brains, possibly being retained in the trans Golgi network. It is unclear if the
absence of vesicular zinc cause the m h  associated neurological
abnormalities. Mice have been generated that are deficient in the ZnT-3
transporter (Cole et al., 1999), and as in the Kantheti et al. (1998) study there
is no zinc staining in the mossy fibers. Interestingly, the ZnT3 deficient mice
do not appear to have such striking neurological phenotypes as the mh mice.
This might suggest that the mh phenotypes are probably caused by the
missorting of other AP-3 dependent cargo molecules and not just ZnT-3
alone.
Hypopigmentation in mh and pe mice
Both mh and pe mice have a reduction in the amount of eye, skin and hair
pigmentation, although these tissues still contain pigmented melanosomes.
As the mice have reduced pigmentation, the sorting of the key melanogenic
enzyme tyrosinase has been investigated. Tyrosinase is a type I
transmembrane protein that contains potential dileucine and tyrosine based
sorting motifs (Honing et al., 1998). A study by Honig et al. (1998) suggested
that the dileucine motif in tyrosinase is able to bind to the AP-3 complex. The
sorting of tyrosinase does not appear to be grossly effected in primary
melanocytes derived from mh and pe mice, with active tyrosinase present in
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late endocytic structures (Alex C. Theos, personal communication).
Interestingly, there is a very early paper that shows tyrosinase activity in
clathrin-coated vesicles (Maul and Brumbaugh, 1971). This paper in
conjunction with the above findings would suggest that tyrosinase is not
sorted via AP-3 but possibly by the AP-1 complex to the melanosome, since
our results indicate that AP-3 is not associated with clathrin-coated vesicles
(Simpson et al., 1996) (Simpson et al., 1997). These findings would suggest
that the defects in pigmentation in mh and pe mice are not due to the direct
mislocalisation of tyrosinase but possibly other factors that might be required
for the activity of tyrosinase. Alternatively there might be somewhat less
efficient sorting of tyrosinase and other melanosomal markers that could lead
to decreased melanin biosynthesis, without affecting the overall distribution of
tyrosinase.
Both these studies indicate that the analysis of the mutant phenotypes will
provide a large amount of information about the molecules that can and can
not interact with the AP-3 complex, but it will take a lot more research to
directly relate the loss of functional AP-3 complex to the many phenotypes
observed in these mice.
In conclusion, the AP-3 complex, like the other adaptor complexes consists of
a b  subunit, a a /g  ( d ) subunit, a m  subunit and a s  subunit. Analysis of
organisms defective in AP-3 complex have revealed that the AP-3 complex is
involved in the trafficking of proteins to lysosomes or lysosome like
organelles. Interestingly, there are a large group of mutants in Drosophilia and
mice that give phenotypes similar to the loss of functional AP-3 complex.
Analysis of these other mutants should hopefully give further insights into the
AP-3 dependent pathway.
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